СУЛЬФОНИМИДОИЛ БЕНЗАМИДЫ С ГЕРБИЦИДНЫМ ДЕЙСТВИЕМ

Abstract

Описаны сульфонимидоилбензамиды формулы (I) в качестве гербицидов. В данной формуле (I), X, W, Z, R, R' и R'' означают радикалы, такие как алкил, циклоалкил, галогеналкил и галоген.

Description

[0001] BCS231028 Ausland Mak / lep 2024-08-30 - 1 - Herbicidally active sulfonimidoylbenzamides The invention relates to the technical field of herbicides, in particular to herbicides for the selective control of weeds and grass weeds in crops. WO 2011 / 035874 A1 discloses herbicidally active N-(1,2,5-oxadiazol-3-yl)benzamides. Certain N-(tetrazol-5-yl)- and N-(triazol-5-yl)benzamides and -nicotinamides are known as herbicides from the earlier-priority, non-prepublished European patent application EP10174893. Herbicidal 3-(sulfin- and sulfonimidoyl)-benzamides are known from WO 2013 / 124228. However, the herbicidal efficacy and / or crop tolerance of the compounds mentioned in these documents is not always sufficient. The object of the present invention was to provide herbicidally active compounds with improved properties compared to the compounds known from the prior art. It has now been found that certain sulfonimidoylbenzamides bearing an unsubstituted 1,3,4-oxadiazole on the amide nitrogen are particularly suitable as herbicides. The present invention thus provides sulfonimidoylbenzamides of the formula (I) or salts thereof. where the (C3-C6)-cycloalkyl, Z means halogen, cyano, (C1-C6)-alkyl, halogen-(C1-C6)-alkyl, (C2-C6)-alkenyl, halogen-(C2-C6)-alkenyl, (C2-C6)-alkynyl, halogen-(C3-C6)-alkynyl, (C3-C6)-cycloalkyl, Halogen-(C3-C6)-cycloalkyl, halogen-(C1-C6)-alkoxy, (C1-C6)-Alkylsulfonyl, W is hydrogen, halogen, R is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C1-C6)-alkoxy-(C1-C6)-alkyl, R' is hydrogen, cyano, (C1-C6)-alkyl, BCS231028 Ausland - 2 - R'' is hydrogen, (C1-C6)-alkylcarbonyl. In formula (I) and all subsequent formulas, alkyl radicals having more than two carbon atoms can be straight-chain or branched. Alkyl radicals are, for example, methyl, ethyl, n- or -i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1,3-dimethylbutyl.Analogously, alkenyl means, for example, allyl, 1-methylprop-2-en-1-yl, 2-methyl-prop-2-en-1-yl, but-2-en-1-yl, but-3-en-1-yl, 1-methyl-but-3-en-1-yl, and 1-methyl-but-2-en-1-yl. Alkynyl means, for example, propargyl, but-2-yn-1-yl, but-3-yn-1-yl, and 1-methyl-but-3-yn-1-yl. The multiple bond can be located in any position within the unsaturated radical. "Cycloalkyl" means a carbocyclic, saturated ring system with three to six carbon atoms, for example, cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl. “Haloalkyl”, “haloalkenyl” and “haloalkynyl” mean alkyl, alkenyl or alkynyl which are partially or fully substituted by identical or different halogen atoms, e.g. monohaloalkyl (= monohaloalkyl) such as CH2CH2Cl, CH2CH2Br, CHClCH3, CH2Cl, CH2F; dihaloalkyl (= dihaloalkyl) such as CH2CHF2, CH2CHCl2, CH2CHBr2, CF2CH3, CHCl2, CHF2; perhaloalkyl such as CCl3, CFCl2, CClF2, CF3, CF2CClF2, CF2CClFCF3; polyhaloalkyl such asCH2CHFCl, CF2CClFH, CF2CBrFH, CH2CF3; The term perhaloalkyl also includes the term perfluoroalkyl. "Alkoxy" means an alkyl radical bonded via an oxygen atom, e.g. B. (but not limited to) (C1-C6) alkoxy such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-Trimethylpropoxy, 1,2,2-Trimethylpropoxy, 1-Ethyl-1-methylpropoxy, and 1-Ethyl-2-methylpropoxy. "Alkoxyalkyl" stands for an alkoxy radical bonded via an alkyl group. "Haloalkoxy" means a halogenalkyl radical bonded via an oxygen atom, e.g.(aber nicht beschränkt auf) OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3 und OCH2CH2Cl. Erfindungsgemäß steht "Alkylthio" für geradkettiges oder verzweigtes S-Alkyl, z.B. (C1-C6)-Alkylthio wie Methylthio, Ethylthio, Propylthio, 1-Methylethylthio, Butylthio, 1-Methylpropylthio, 2- Methylpropylthio, 1,1-Dimethylethylthio, Pentylthio, 1-Methylbutylthio, 2-Methylbutylthio, 3- Methylbutylthio, 1,1-Dimethylpropylthio, 1,2-Dimethylpropylthio, 2,2-Dimethylpropylthio, 1- Ethylpropylthio, Hexylthio, 1-Methylpentylthio, 2-Methylpentylthio, 3-Methylpentylthio, 4-Methyl- pentylthio, 1,1-Dimethylbutylthio, 1,2-Dimethylbutylthio, 1,3-Dimethylbutylthio, 2,2-Dimethylbutylthio, 2,3-Dimethylbutylthio, 3,3-Dimethylbutylthio, 1-Ethylbutylthio, 2-Ethylbutylthio, 1,1,2-Tri- BCS231028 Ausland - 3 - methylpropylthio, 1,2,2-Trimethylpropylthio, 1-Ethyl-1-methylpropylthio und 1-Ethyl-2-methyl- propylthio."Alkylcarbonyl" (alkyl-C(=O)-), unless defined otherwise elsewhere, stands for alkyl radicals bonded to the skeleton via -C(=O)-, such as (C1-C6)-alkylcarbonyl. The number of C atoms refers to the alkyl radical in the alkylcarbonyl group. The term "halogen" means, for example, fluorine, chlorine, bromine, or iodine. If the term is used for a radical, then "halogen" means, for example, a fluorine, chlorine, bromine, or iodine atom. If the compounds can form tautomers by hydrogen shift that would not be structurally covered by formula (I), these tautomers are nevertheless encompassed by the definition of the compounds of formula (I) according to the invention, unless a specific tautomer is the subject of consideration.For example, many carbonyl compounds can exist in both the keto and enol forms, both forms being encompassed by the definition of a compound of formula (I). Depending on the nature and linkage of the substituents, compounds of general formula (I) can exist as stereoisomers. If, for example, one or more asymmetrically substituted carbon atoms are present, enantiomers and diastereomers can occur. Furthermore, the sulfur atom in the sulfoximino group acts as a chiral center. Stereoisomers can be obtained from the mixtures obtained during production using conventional separation methods, for example, chromatographic separation processes. Stereoisomers can also be selectively prepared using stereoselective reactions using optically active starting materials and / or auxiliaries.The invention also relates to all stereoisomers and mixtures thereof which are encompassed by the general formula (I) but are not specifically defined. The invention also relates to all E- / Z-isomers and mixtures thereof which are encompassed by the general formula (I) but are not specifically defined. The compounds of the formula (I) can form salts. Salt formation can take place by the action of a base on those compounds of the formula (I) which carry an acidic hydrogen atom, e.g. in the case of R''. Suitable bases are, for example, organic amines, such as trialkylamines, morpholine, piperidine or pyridine, and also ammonium, alkali or alkaline earth metal hydroxides, carbonates and bicarbonates, in particular sodium and potassium hydroxide, sodium and potassium carbonate and sodium and potassium bicarbonate.These salts are compounds in which the acidic hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular alkali metal salts or alkaline earth metal salts, in particular sodium and potassium salts, or also ammonium salts, salts with organic amines or quaternary ammonium salts, for example with cations of the formula [NRR*R**R***]. +, wherein R, R*, R** and R*** independently of one another each represent an organic radical, in particular alkyl, aryl, aralkyl or alkylaryl. Also suitable are alkylsulfonium and alkylsulfoxonium salts, such as (C1-C4)-trialkylsulfonium and (C1-C4)-trialkylsulfoxonium salts. The compounds of the formula (I) can form salts by addition of a suitable inorganic or organic acid, for example mineral acids such as HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, for example carboxylic acids such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid or sulfonic acids, such as p-toluenesulfonic acid, to a basic group, such as amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino. These salts then contain the conjugate base of the acid as an anion.Preference is given to compounds of the general formula (I) in which X is halogen, (C1-C3)-alkyl, (C1-C3)-alkoxy, (C3-C6)-cycloalkyl, Z is halogen, (C1-C3)-alkyl, halogen-(C1-C3)-alkyl, (C3-C6)-cycloalkyl, halogen-(C1-C3)-alkoxy, W is hydrogen, fluorine, R is (C1-C3)-alkyl, R' is hydrogen, R'' is hydrogen. Particular preference is given to compounds of the general formula (I) in which X is chlorine, methyl, ethyl, methoxy, cyclopropyl, Z is chlorine, methyl, difluoromethyl, trifluoromethyl, cyclopropyl, trifluoromethoxy, W is hydrogen, R is methyl, ethyl, R' is hydrogen, R'' is hydrogen. The compounds according to the invention can be prepared by methods described in WO 2013 / 124228. For example, the compounds according to the invention can be prepared stepwise, first at the thioether stage of the formula (I-thioether) according to the method given in Scheme 1 by base-catalyzed. BCS231028 Foreign Countries - 5 - reaction of a benzoic acid chloride (II) with a 2-amino-1,3,4-oxadiazole (VII). The thioether intermediates can then be prepared according to Scheme a 4 into the sulfonimidoylbenzamides of the formula (I) according to the invention. E Stage of formula (I-thioether) according to the method shown in Scheme 2 by reacting a benzoic acid of formula (IV) with a 2-amino-1,3,4-oxadiazole (VII). The thioether intermediates can then be converted into the inventive ßen sulfonimidoylbenzamides of formula (I). F for Amidation reactions, such as 1,1`-carbonyldiimidazole (CDI), dicyclohexylcarbodiimide (DCC), 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide 3P). BCS231028 Abroad - 6 - invention Compounds in which the substituent R'' is where R is hydrogen, can be prepared, for example, according to the method shown in Scheme 3 by reacting an N-(1,3,4-oxadiazol-2-yl)-arylcarboxamide (I-NH) with a compound of the general formula (VIII), where L is a leaving group such as chlorine, bromine, iodine, mesyloxy, tosyloxy, trifluorosulfonyloxy, etc.: names in literature described methods. The compounds of formula (I) according to the invention can be prepared, for example, from the corresponding thioethers of formula (I-thioether) (Scheme 4). For this purpose, the thioether is converted, for example, with cyanamide and an oxidizing agent (iodosobenzene diacetate, sodium hypochlorite, or N-bromosuccinimide) into the corresponding sulfilimine, which can be further oxidized to sulfoximine. Oxidizing agents such as meta-chloroperbenzoic acid, sodium permanganate, or a mixture of sodium periodate and ruthenium trichloride are suitable for the oxidation to sulfoximine. NH-sulfoximines are accessible, for example, from sulfoxides with sodium azide and sulfuric acid and can be functionalized at the nitrogen atom with reagents such as cyanogen bromide, acid chlorides or acid anhydrides, chloroformate, nitric acid, or other compounds.The oxidation of N-sulfonated sulfilimines to the corresponding sulfoximines is achieved, for example, with hydrogen peroxide. Alternatively, sulfoxides can be converted to N-acylated or N-sulfonated sulfoximines. The carboxamide or sulfonamide can then be cleaved to the NH-sulfoximine. Such synthetic methods for the generation of sulfilimines and sulfoximines from thioethers or for the generation of sulfoximines from sulfoxides or for the derivatization of sulfilimines and sulfoximines, including NH-sulfoximines, can be found, for example, in Bolm, C. Org. Lett. 2004, 6, 1305; Bolm, C. Org. Lett. 2007, 9, 3809; Bolm, C. Synthesis 2010, 17, 2922; Bolm, C. Adv. Synth. Catal.2010, 352, 309; WO 2007 / 095229, WO 2008 / 141843, US 2008 / 0207910, US 2008 / 0194634 and US 2010 / 0056534. BCS231028 Abroad - 7 - If necessary, protective groups may be used for such syntheses to achieve sufficient selectivity. In particular, functionalization at the NH-sulfoximine is fundamentally in competition with the analogous functionalization at the amide nitrogen atom. It may be advantageous to change the sequence of reaction steps. Benzoic acids bearing a sulfoxide cannot be readily converted into their acid chlorides. In this case, it is advisable to first prepare the amide at the thioether stage and then oxidize the thioether to the sulfoxide. Sulfoximines and especially sulfilimines are not sufficiently stable under some conditions (Bolm, C. Adv. Synth. Catal. 2010, 352, 309), so it may be advantageous, as shown in the schemes above, to first synthesize the benzamide at the thioether stage and only at the end of the synthesis sequence to generate the sulfilimine or the sulfoximine from the thioether.However, depending on the substitution pattern, if stability is sufficient, it may also be advisable to first generate the sulfilimine or sulfoximine from the thioether at the benzoic acid stage (or in an even earlier step) and only then convert the benzoic acid into its amide. In some cases, it may be advantageous to use derivatives of it rather than free benzoic acid for the reactions. Sometimes, for the stability of a functional group, it is sufficient to operate only in acidic or basic media, i.e., to work only with the free benzoic acid or only with its salt. In many cases, esters such as methyl or ethyl esters are suitable. Tert-butyl esters often sterically shield the carboxyl group against nucleophilic reagents and are easily cleavable in acidic media (TW Greene, PGM Wuts, Protective Groups in Organic Synthesis, 2nd Edition, John Wiley & Sons, Inc. 1991, p. 227 ff.).Also suitable are residues that are significantly more stable than carboxyl groups, yet are easily accessible from carboxylic acids and can also be easily converted back into the free carboxylic acids. These include, for example, oxazolines. BCS231028 Abroad - 8 - (TW Greene, PG M . Wuts, Protective Groups in Organic Synthesis, 2nd Edition , John Wiley & Sons, Inc.1991, p. 265 ff.; Z . Hell et al, Tetrahedron Letters 43 (2002), 3985 - 3987). Furthermore, it is also possible to obtain the NH-sulfoximes of the formula (I) according to the invention in one step from the corresponding thioethers of the formula (I-thioether) (Scheme 5). For this purpose, the thioether is, for example, ise with ammonium carbamate and iodosobenzene diacetate (JA Bull et al. Synlett 2017, 28, 2525-2538) directly into the corresponding NH-sulfoximines. In the above processes, the compounds of formula (I) are obtained as racemic mixtures. The pure enantiomers can be obtained therefrom by methods known to the person skilled in the art. chiral separation methods, such as chromatographic enantiomer separation on chiral support materials. The workup of the respective reaction mixtures is generally carried out by known methods, for example by crystallization, aqueous extractive workup, chromatographic methods, or a combination of these methods. Collections of compounds of formula (I) and / or their salts, which can be synthesized by the above-mentioned reactions, can also be prepared in a parallel manner, whereby this can be done manually, partially automated, or fully automated. It is possible, for example, to automate the reaction procedure, the workup, or the purification of the products or intermediates. Overall, this refers to a procedure such as that described, for example, by D.Tiebes in Combinatorial Chemistry – Synthesis, Analysis, Screening (editor Günther Jung), Wiley Publishers 1999, pages 1 to 34. A range of commercially available devices can be used for parallel reaction execution and work-up, for example Calpyso reaction blocks (Caylpso reaction blocks) from Barnstead International, Dubuque, Iowa 52004-0797, USA or reaction stations from Radleys, Shirehill, Saffron Walden, Essex, CB 113AZ, England or MultiPROBE Automated Workstations from Perkin Elmar, Waltham, Massachusetts 02451, USA. For the parallel purification of compounds of general formula (I) and their salts or of intermediates obtained during the preparation, chromatography apparatuses are available, for example from ISCO, Inc., 4700 Superior Street, Lincoln, NE 68504, USA.The equipment listed leads to a modular approach in which the individual work steps are automated, but manual operations must be performed between the work steps. This can be avoided by using partially or fully integrated automation systems in which the respective automation modules are operated, for example, by robots. Such automation systems can be obtained, for example, from Caliper, Hopkinton, MA 01748, USA. The execution of individual or multiple synthesis steps can be supported by the use of polymer-supported reagents / scavenger resins. A number of experimental protocols are described in the specialist literature, for example in ChemFiles, Vol. 4, No. 1, Polymer-Supported Scavengers and Reagents for Solution-Phase Synthesis (Sigma-Aldrich).In addition to the methods described here, the preparation of compounds of general formula (I) and their salts can be carried out entirely or partially by solid-phase-assisted methods. For this purpose, individual intermediates or all intermediates of the synthesis, or of a synthesis adapted for the corresponding procedure, are bound to a synthetic resin. Solid-phase-assisted synthesis methods are well described in the specialist literature, e.g., Barry A. Bunin in "The Combinatorial Index," Academic Press, 1998, and Combinatorial Chemistry – Synthesis, Analysis, Screening (editor Günther Jung), Wiley, 1999. The use of solid-phase-assisted synthesis methods allows for a number of well-known protocols, which can be carried out manually or automatically.The reactions can be carried out, for example, using IRORI technology in microreactors from Nexus Biosystems, 12140 Community Road, Poway, CA 92064, USA. The implementation of individual or multiple synthesis steps in both the solid and liquid phases can be supported by the use of microwave technology. A number of experimental protocols are described in the specialist literature, for example in Microwaves in Organic and Medicinal Chemistry (editors: C.O. Kappe and A. Stadler), published by Wiley, 2005. Preparation according to the processes described here yields compounds of formula (I) and their salts in the form of collections of substances called libraries. The present invention also relates to libraries containing at least two compounds of formula (I) and their salts.The compounds of the formula (I) according to the invention (and / or salts thereof), hereinafter referred to collectively as "compounds according to the invention", have excellent herbicidal activity against a broad spectrum of economically important mono- and dicotyledonous annual weeds. BCS231028 Ausland - 10 - Even difficult-to-control perennial weeds which sprout from rhizomes, rootstocks or other permanent organs are effectively controlled by the active compounds. The present invention therefore also relates to a method for controlling undesirable plants or for regulating the growth of plants, preferably in plant crops, in which one or more compounds according to the invention are applied to the plants (e.g. weeds such as mono- or dicotyledonous weeds or undesirable crop plants), the seed (e.g. grains, seeds or vegetative propagation organs such as tubers or shoot parts with buds) or the area on which the plants grow (e.g.The compounds according to the invention can be applied, for example, by pre-sowing (if necessary also by incorporation into the soil), pre-emergence, or post-emergence methods. Some examples of monocotyledonous and dicotyledonous weed flora that can be controlled by the compounds according to the invention are mentioned in detail, without implying a restriction to specific species. Monocotyledonous harmful plants of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.Dicotyledonous weeds of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the compounds of the invention are applied to the soil surface before germination, either the emergence of weed seedlings is completely prevented or the weeds grow to the cotyledon stage, but then cease growth and finally die completely after three to four weeks.When the active ingredients are applied post-emergence to the green parts of the plant, growth stops after treatment and the weeds remain in the growth stage present at the time of application or die completely after a certain time, thus eliminating weed competition harmful to the crop plants very early and sustainably. Although the compounds according to the invention have excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, crop plants of economically important crops, e.g.Dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Triticale, Triticum, Zea, in particular Zea and Triticum, are only insignificantly damaged or not damaged at all, depending on the structure of the respective compound according to the invention and the application rate. For these reasons, the present compounds are very suitable for the selective control of undesirable plant growth in plant crops such as agricultural crops or ornamental plantings. Furthermore, the compounds according to the invention (depending on their respective structure and the applied rate) exhibit excellent growth regulatory properties in crop plants.They regulate the plant's own metabolism and can thus be used to specifically influence plant components and facilitate harvesting, for example, by inducing desiccation and stunting. Furthermore, they are also suitable for the general control and inhibition of undesirable vegetative growth without killing the plants. Inhibition of vegetative growth plays a major role in many monocotyledonous and dicotyledonous crops, as it can, for example, reduce or completely prevent lodging. Due to their herbicidal and plant growth-regulating properties, the active ingredients can also be used to control weeds in crops of plants modified genetically or through conventional mutagenesis.The transgenic plants are generally characterized by particularly advantageous properties, for example, resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria, or viruses. Other special properties relate, for example, to the harvested product in terms of quantity, quality, storability, composition, and specific ingredients. For example, transgenic plants with increased starch content or altered starch quality, or those with a different fatty acid composition of the harvested product, are known. With regard to transgenic crops, the use of the compounds according to the invention is preferred in economically important transgenic crops of crops and ornamental plants, e.g.of cereals such as wheat, barley, rye, oats, millet, rice, and maize, or also crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas, and other vegetables. The compounds according to the invention can preferably be used as herbicides in crops that are resistant to the phytotoxic effects of the herbicides or have been genetically engineered to be resistant. Conventional ways of producing new plants that have modified properties compared to previously occurring plants include, for example, classical breeding methods and the generation of mutants. Alternatively, new plants with modified properties can be produced using genetic engineering methods (see, for example, EP-A-0221044, EP-A-0131624). For example, several cases have been described: genetic modifications of crop plants for the purpose of modifying the starch synthesized in the plants (e.g.,WO 92 / 11376, WO 92 / 14827, WO 91 / 19806), - transgenic crop plants which are resistant to certain herbicides of the glufosinate type (cf., for example, EP-A-0242236, EP-A-242246) or glyphosate (WO 92 / 00377) or sulfonylurea type (EP-A-0257993, US-A-5013659), - transgenic crop plants, for example cotton, with the ability to produce Bacillus thuringiensis toxins (Bt toxins), which make the plants resistant to certain pests (EP-A-0142924, EP-A-0193259), - transgenic crop plants with a modified fatty acid composition (WO 91 / 13972). - genetically modified crops with new ingredients or secondary substances, e.g. new phytoalexins, which cause increased disease resistance (EPA 309862, EPA0464461) - genetically modified plants with reduced photorespiration that have higher yields and greater stress tolerance (EPA 0305398).- Transgenic crop plants that produce pharmaceutically or diagnostically important proteins ("molecular pharming") - Transgenic crop plants that are characterized by higher yields or better quality - Transgenic crop plants that are characterized by a combination of, for example, the above-mentioned new properties ("gene stacking"). Numerous molecular biological techniques with which new transgenic plants with modified properties can be produced are known in principle, see, for example, B. I. Potrykus and G. Spangenberg (eds.) Gene Transfer to Plants, Springer Lab Manual (1995), Springer Verlag Berlin, Heidelberg, or Christou, "Trends in Plant Science" 1 (1996) 423-431). For such genetic manipulations, nucleic acid molecules can be introduced into plasmids that allow mutagenesis or sequence modification through recombination of DNA sequences. Using standard procedures, for example,Base exchanges can be made, partial sequences removed, or natural or synthetic sequences added. Adapters or linkers can be attached to the DNA fragments to connect them together; see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, or Winnacker "Gene and Clones," VCH Weinheim, 2nd ed. 1996. The production of plant cells with reduced activity of a gene product can be achieved, for example, by expressing at least one corresponding antisense RNA, a sense RNA to achieve a cosuppression effect, or the expression of at least one appropriately constructed ribozyme that specifically cleaves transcripts of the aforementioned gene product.For this purpose, DNA molecules can be used that comprise the entire coding sequence of a gene product, including any flanking sequences that may be present, as well as DNA molecules that comprise only parts of the coding sequence, whereby these parts must be long enough to produce an antisense effect in the cells. It is also possible to use DNA sequences that have a high degree of homology to the coding sequences of a gene product, but are not completely identical. When nucleic acid molecules are expressed in plants, the synthesized protein can be localized in any compartment of the plant cell. However, to achieve localization in a specific compartment, the coding region can, for example, be linked to DNA sequences that ensure localization in a specific compartment. Such sequences are known to the person skilled in the art (see, for example, Braun et al., EMBO J.11 (1992), 3219-3227, Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850, Sonnewald et al., Plant J. 1 (1991), 95-106). The expression of the nucleic acid molecules can also take place in the organelles of the plant cells. The transgenic plant cells can be regenerated into whole plants using known techniques. The transgenic plants can in principle be plants of any plant species, i.e. both monocotyledonous and dicotyledonous plants. In this way, transgenic plants are obtainable which have altered properties through overexpression, suppression or inhibition of homologous (= natural) genes or gene sequences or expression of heterologous (= foreign) genes or gene sequences. The compounds according to the invention can preferably be used in transgenic cultures which are resistant to growth factors, such as, for example, B. Dicamba or against herbicides that destroy essential plant enzymes, e.g.Inhibit acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), or are resistant to herbicides from the group of sulfonylureas, glyphosates, glufosinates or benzoyl isoxazoles and analogous active ingredients. When the active ingredients according to the invention are used in transgenic crops, in addition to the effects on weeds observed in other crops, effects often occur that are specific to the application in the respective transgenic crop, for example a modified or specifically expanded weed spectrum that can be controlled, modified application rates that can be used for application, preferably good combinability with the herbicides to which the transgenic crop is resistant, and influence on the growth and yield of the transgenic crops.BCS231028 Foreign Countries - 14 - The invention therefore also relates to the use of the compounds of the formula (I) according to the invention and / or salts thereof as herbicides for controlling weeds in crops of useful or ornamental plants, optionally in transgenic crops. The use according to the invention for controlling weeds or for regulating the growth of plants also includes the case in which the active ingredient of the formula (I) or its salt is formed from a precursor substance ("prodrug") only after application to the plant, in the plant or in the soil. The invention also relates to the use of one or more compounds of the formula (I) or salts orof an agent according to the invention (as defined below) (in a method) for controlling weeds or for regulating the growth of plants, characterized in that an effective amount of one or more compounds of the formula (I) or salts thereof is applied to the plants (weeds, optionally together with the useful plants), plant seeds, the soil in or on which the plants grow, or the area cultivated. The invention also relates to a herbicidal and / or plant growth regulating agent, characterized in that the agent (a) comprises one or more compounds of the formula (I) and / or salts thereof as defined above, preferably in one of the preferred orparticularly preferred embodiment, in particular one or more compounds of the formulas 1-1 to 1-33 and / or salts thereof, in each case as defined above, and (b) one or more further substances selected from groups (i) and / or (ii): (i) one or more further agrochemically active substances, preferably selected from the group consisting of insecticides, acaricides, nematicides, further herbicides (i.e. those which do not correspond to the formula (I) defined above), fungicides, safeners, fertilizers and / or further growth regulators, (ii) one or more formulation auxiliaries customary in plant protection. The further agrochemically active substances of component (i) of an agent according to the invention are preferably selected from the group of substances listed in "The Pesticide Manual", 19. thedition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2021. A herbicidal or plant growth-regulating agent according to the invention preferably comprises one, two, three or more formulation auxiliaries (ii) customary in crop protection, selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, dusts, carriers that are solid at 25°C and 1013 mbar, preferably adsorptive, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer substances, antifoams, water, organic solvents, preferably organic solvents miscible with water in any ratio at 25°C and 1013 mbar. The compounds according to the invention can be used in the form of wettable powders, emulsifiable concentrates, sprayable solutions,Dusts or granules in the usual preparations. The invention therefore also relates to herbicidal and plant growth regulating agents containing the compounds according to the invention. The compounds according to the invention can be formulated in various ways, depending on the biological and / or chemical-physical parameters specified. Possible formulation options include, for example: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), oil- or water-based dispersions, oil-miscible solutions, capsule suspensions (CS), dusts (DP), seed dressings, granules for broadcast and soil application, granules (GR) in the form of microgranules, spray granules, coating granules, and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG),ULV formulations, microcapsules, and waxes. These individual formulation types are known in principle and are described, for example, in: Winnacker-Küchler, "Chemical Technology," Volume 7, C. Hanser Verlag, Munich, 4th ed., 1986; Wade van Valkenburg, "Pesticide Formulations," Marcel Dekker, NY, 1973; and K. Martens, "Spray Drying" Handbook, 3rd ed., 1979, G. Goodwin Ltd., London. The necessary formulation aids such as inert materials, surfactants, solvents and other additives are also known and are described, for example, in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers", 2nd Ed., Darland Books, Caldwell NJ, Hv Olphen, "Introduction to Clay Colloid Chemistry", 2nd Ed., J. Wiley & Sons, NY, C. Marsden, "Solvents Guide", 2nd Ed., Interscience, NY1963, McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood NJ, Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., NY 1964, Schönfeldt,"Surface-active ethylene oxide adducts," Wiss. Verlagsgesell., Stuttgart 1976; Winnacker-Küchler, "Chemische Technologie," Volume 7, C. Hanser Verlag, Munich, 4th ed. 1986. These formulations can also be used to produce combinations with other pesticidally active substances, such as insecticides, acaricides, herbicides, fungicides, as well as with safeners, fertilizers, and / or growth regulators, e.g., in the form of a ready-to-use formulation or as a tank mix. Suitable safeners include mefenpyr diethyl, cyprosulfamide, isoxadifen ethyl, cloquintocetmexyl, and dichlormide. BCS231028 Foreign Countries - 16 - Wettable powders are preparations which are uniformly dispersible in water and which, in addition to the active ingredient and a diluent or inert substance, also contain surfactants of an ionic and / or non-ionic nature (wetting agents, dispersants), e.g. polyoxyethylated alkylphenols, polyoxyethylated fatty alcohols, polyoxyethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates,sodium ligninsulfonate, 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate, or sodium oleoylmethyltaurine. To produce the wettable powders, the herbicidal active ingredients are finely ground in conventional equipment such as hammer mills, fan mills, and air jet mills and mixed simultaneously or subsequently with the formulation auxiliaries. Emulsifiable concentrates are produced by dissolving the active ingredient in an organic solvent, e.g., butanol, cyclohexanone, dimethylformamide, xylene, or higher-boiling aromatics or hydrocarbons, or mixtures of the organic solvents, with the addition of one or more ionic and / or non-ionic surfactants (emulsifiers). Examples of emulsifiers that can be used are: alkylarylsulfonic acid calcium salts such as Ca-dodecylbenzenesulfonate or non-ionic emulsifiers such as fatty acid polyglycol esters, alkylaryl polyglycol ethers,Fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters such as sorbitan fatty acid esters or polyoxyethylene sorbitan esters such as polyoxyethylene sorbitan fatty acid esters. Dusts are obtained by grinding the active ingredient with finely divided solid substances, e.g., talc, natural clays such as kaolin, bentonite, and pyrophyllite, or diatomaceous earth. Suspension concentrates can be water- or oil-based. They can be produced, for example, by wet grinding using commercially available bead mills and, if appropriate, with the addition of surfactants, such as those listed above for the other formulation types. Emulsions, such as oil-in-water emulsions (EW), can be prepared, for example, using stirrers, colloid mills, and / or static mixers using aqueous organic solvents and, if appropriate, surfactants, such as those listed above for the other formulation types.Granules can be produced either by spraying the active ingredient onto adsorptive, granulated inert material or by applying active ingredient concentrates to the surface of carriers such as sand, kaolinite, or granulated inert material using adhesives, e.g., polyvinyl alcohol, sodium polyacrylate, or mineral oils. Suitable active ingredients can also be granulated in the manner customary for the production of fertilizer granules—if desired, mixed with fertilizers. Water-dispersible granules are generally produced using conventional processes such as spray drying, fluidized-bed granulation, disc granulation, mixing with high-speed mixers, and extrusion without solid inert material. For the production of disc, fluidized bed, extruder and spray granules see e.g. procedures in "Spray-Drying Handbook" 3rd ed.1979, G. Goodwin Ltd., London, JE Browning, "Agglomeration",Chemical and Engineering 1967, pages 147 ff., "Perry's Chemical Engineer's Handbook", 5th Ed., McGraw-Hill, New York 1973, pp. 8-57. For further details on the formulation of crop protection products, see, for example, GC Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pages 81-96 and JD Freyer, SA Evans, "Weed Control Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103. The agrochemical preparations generally contain 0.1 to 99% by weight, in particular 0.1 to 95% by weight, of compounds according to the invention. In wettable powders, the active ingredient concentration is, for example, about 10 to 90% by weight, the remainder to 100% by weight consisting of conventional formulation components. In emulsifiable concentrates, the active ingredient concentration can be approximately 1 to 90, preferably 5 to 80 wt.%. Dust-form formulations contain 1 to 30 wt.% active ingredient, preferably 5 to 20 wt.% active ingredient.Sprayable solutions contain approximately 0.05 to 80, preferably 2 to 50 wt.% active ingredient. In water-dispersible granules, the active ingredient content depends partly on whether the active compound is liquid or solid and which granulation aids, fillers, etc. are used. In water-dispersible granules, the active ingredient content is, for example, between 1 and 95 wt.%, preferably between 10 and 80 wt.%. In addition, the active ingredient formulations mentioned may contain the usual adhesives, wetting agents, dispersants, emulsifiers, penetration agents, preservatives, antifreeze agents, solvents, fillers, carriers, dyes, defoamers, evaporation inhibitors, and agents that influence pH and viscosity. Examples of formulation aids can be found, among others, in "Chemistry and Technology of Agrochemical Formulations," ed. DA Knowles,Kluwer Academic Publishers (1998). The compounds of formula (I) or their salts can be used as such or in the form of their preparations (formulations) in combination with other pesticidally active substances, such as insecticides, acaricides, nematicides, herbicides, fungicides, safeners, fertilizers, and / or growth regulators, e.g., as a ready-to-use formulation or as tank mixes. The combination formulations can be prepared based on the abovementioned formulations, taking into account the physical properties and stabilities of the active ingredients to be combined. BCS231028 Ausland - 18 - Of particular interest is the selective control of weeds in crops of useful and ornamental plants. Although the compounds (I) according to the invention already exhibit very good to sufficient selectivity in many crops,In principle, phytotoxicity can occur in some crops, especially in the case of mixtures with other herbicides that are less selective. Of particular interest in this regard are combinations of compounds (I) according to the invention that contain the compounds (I) or their combinations with other herbicides or pesticides and safeners. The safeners, which are used in an antidotally effective concentration, reduce the phytotoxic side effects of the herbicides / pesticides used, e.g., in economically important crops such as cereals (wheat, barley, rye, maize, rice, millet), sugar beet, sugar cane, rapeseed, cotton, and soybeans, preferably cereals. The weight ratios of herbicide (mixture) to safener generally depend on the application rate of herbicide and the efficacy of the respective safener and can vary within wide limits, for example, in the range from 200:1 to 1:200.preferably 100:1 to 1:100, in particular 20:1 to 1:20. The safeners can be formulated analogously to the compounds (I) or mixtures thereof with other herbicides / pesticides and can be supplied and applied as a ready-to-use formulation or tank mix with the herbicides. For application, the herbicide or herbicide-safener formulations in commercially available form are diluted, if appropriate, in the customary manner, e.g., in the case of wettable powders, emulsifiable concentrates, dispersions, and water-dispersible granules, with water. Dust-like preparations, soil or broadcast granules, and sprayable solutions are not normally diluted with other inert substances before use. External conditions such as temperature,Humidity, etc., influence to a certain extent the application rate of the compounds of formula (I) and / or their salts. The application rate can vary within wide limits. For use as a herbicide to control weeds, the total amount of compounds of formula (I) and their salts is preferably in the range from 0.001 to 10.0 kg / ha, more preferably in the range from 0.005 to 5 kg / ha, more preferably in the range from 0.01 to 1.5 kg / ha, and most preferably in the range from 0.05 to 1 kg / ha. This applies to both pre-emergence and post-emergence applications. When using compounds of formula (I) and / or salts thereof as plant growth regulators, for example as stalk shorteners in crop plants as mentioned above, preferably in cereal plants such as wheat, barley, rye, triticale, millet, rice or maize, the total application rate is preferably in the range from 0.001 to 2 kg / ha, preferably in the range from 0.0.05 to 1 kg / ha, particularly in the range of 10 to 500 g / ha, most preferably in the range of 20 to 250 g / ha. This applies to both pre-emergence and post-emergence applications. BCS231028 Foreign Countries - 19 - Application as a stem shortener can occur at various stages of plant growth. For example, application after tillering at the beginning of longitudinal growth is preferred. Alternatively, when used as a plant growth regulator, seed treatment is also an option, which includes various seed dressing and coating techniques. The application rate depends on the individual techniques and can be determined in preliminary trials. Suitable combination partners for the compounds of general formula (I) in mixture formulations or in tank mixes are, for example, known active substances which are based on the inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase,Enolpyruvylshikimate 3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, protoporphyrinogen oxidase, or act as plant growth regulators, as described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 19th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2021 and literature cited therein. Known herbicides or plant growth regulators that can be combined with compounds of general formula (I) include, for example, the following active ingredients (the compounds are designated either by the "common name" according to the International Organization for Standardization (ISO) or by the chemical name or code number) and always include all application forms such as acids, salts,Esters and isomers such as stereoisomers and optical isomers. One and sometimes several application forms are mentioned as examples: Acetochlor, Acifluorfen, Acifluorfen-methyl, Acifluorfen-sodium, Aclonifen, Alachlor, Allidochlor, Alloxydim, Alloxydim-sodium, Ametryn, Amicarbazon, Amidochlor, Amidosulfuron, 4-Amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, Aminocyclopyrachlor, Aminocyclopyrachlor-potassium, Aminocyclopyrachlor-methyl, Aminopyralid, Aminopyralid-dimethylammonium, Aminopyralid-tripromine, Amitrol, Ammonium sulfamate, Anilofos, Asulam, Asulam-potassium, Asulam-sodium, Atrazine, Azafenidine, Azimsulfuron, Beflubutamid, (S)-(-)- Beflubutamid, Beflubutamid-M, Benazoline, Benazoline-ethyl, Benazoline-dimethylammonium, Benazolin-Klaium, Benfluralin, Benfuresate, Bensulfuron, Bensulfuron-methyl, Bensulide, Bentazone, Bentazone-Sodium, Benzobicyclon, Benzofenap, Bicyclopyrone, Bifenox, Bilanafos, Bilanafos sodium, Bipyrazone, Bispyribac,Bispyribac-Natium, Bixlozon, Bromacil, Bromacil-lithium, Bromacil-Natrium, Bromobutid, Bromofenoxim, Bromoxynil, Bromoxynilbutyrat, Bromoxynil-Kalium, Bromoxynil- heptanoat und Bromoxynil-octanoat, Busoxinon, Butachlor, Butafenacil, Butamifos, Butenachlor, Butralin, Butroxydim, Butylat, Cafenstrol, Cambendichlor, Carbetamide, Carfentrazon, Carfentrazon- Ethyl, Chloramben, Chloramben-ammonium, Chloramben-diolamin, Chlroamben-methyl, Chloramben- methylammonium, Chloramben-Natium, Chlorbromuron, Chlorfenac, Chlorfenac-ammonium, Chlorfenac-Natium, Chlorfenprop, Chlorfenprop-methyl, Chlorflurenol, Chlorflurenol-methyl, Chloridazon, Chlorimuron, Chlorimuron-ethyl, Chlorophthalim, Chlorotoluron, Chlorsulfuron, Chlorthal, BCS231028 Ausland - 20 - Chlorthal-dimethyl, Chlorthal-monomethyl, Cinidon, Cinidon-ethyl, Cinmethylin, exo-(+)-Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7-oxabicyclo[2.2.1]heptan, exo-(-)- Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7-oxabicyclo[2.2.1]heptan, Cinosulfuron, Clacyfos, Clethodim, Clodinafop, Clodinafop-ethyl, Clodinafop-propargyl, Clomazon, Clomeprop, Clopyralid, Clopyralid-methyl, Clopyralid-olamin, Clopyralid-Kalium, Clopyralid-tripomin, Cloransulam, Cloransulam-methyl, Cumyluron, Cyanamide, Cyanazine, Cycloat, Cyclopyranil, Cyclopyrimorat, Cyclosulfamuron, Cycloxydim, Cyhalofop, Cyhalofop-butyl, Cyprazin, 2,4-D (sowie die Ammonium, Butotyl, Butyl, Cholin, Diethylammonium, Dimethylammonium, Diolamin, Doboxyl, Dodecylammonium, Etexyl, Ethyl, 2-Ethylhexyl, Heptylammonium, Isobutyl, Isooctyl, Isopropyl, Isopropylammonium, Lithium, Meptyl, Methyl, Kalium, Tetradecylammonium, Triethylammonium, Triisopropanolammonium, Tripromin and Trolamin Salze davon), 2,4-DB, 2,4-DB-butyl, 2,4-DB- Dimethylammonium, 2,4-DB-isooctyl, 2,4-DB-Kalium und 2,4-DB-Natrium, Daimuron (Dymron), Dalapon, Dalapon-Calcium, Dalapon-Magnesium, Dalapon-Natium, Dazomet, Dazomet-Natrium,n- Decanol, 7-Deoxy-D-sedoheptulose, Desmedipham, Detosyl-pyrazolat (DTP), Dicamba und seine Salze (z.B. Dicamba-biproamin, Dicamba-N,N-Bis(3-aminopropyl)methylamin, Dicamba-butotyl, Dicamba- cholin, Dicamba-Diglycolamin, Dicamba-Dimethylammonium, Dicamba-Diethanolaminemmonium, Dicamba-Diethylammonium, Dicamba-isopropylammonium, Dicamba-methyl, Dicamba- monoethanolamin, Dicamba-olamin, Dicamba-Kalium, Dicamba-Natium, Dicamba-Triethanolamin), Dichlobenil, 2-(2,4-Dichlorbenzyl)-4,4-dimethyl-1,2-oxazolidin-3-on, 2-(2,5-Dichlorbenzyl)-4,4- dimethyl-1,2-oxazolidin-3-one, Dichlorprop, Dichlorprop-butotyl, Dichlorprop-Dimethylammonium, Dichhlorprop-etexyl, Dichlorprop-ethylammonium, Dichlorprop-isoctyl, Dichlorprop-methyl, Dichlorprop-Kalium, Dichlorprop-Natrium, Dichlorprop-P, Dichlorprop-P-Dimethylammonium, Dichlorprop-P-etexyl, Dichlorprop-P-Kalium, Dichlorprop-Natrium, Diclofop, Diclofop-methyl, Diclofop-P, Diclofop-P-methyl, Diclosulam, Difenzoquat, Difenzoquat-metilsulfate,Diflufenican, Diflufenzopyr, Diflufenzopyr-Natrium, Dimefuron, Dimepiperate, Dimesulfazet, Dimethachlor, Dimethametryn, Dimethenamid, Dimethenamid-P, Dimetrasulfuron, Dinitramine, Dinoterb, Dinoterb- Acetate, Diphenamid, Diquat, Diquat-Dibromid, Diquat-Dichloride, Dithiopyr, Diuron, DNOC, DNOC- Ammonium, DNOC-Kalium, DNOC-Natrium, Endothal, Endothal-Diammonium, Endothal-Dikalium, Endothal-Dinatrium, Epyrifenacil (S-3100), EPTC, Esprocarb, Ethalfluralin, Ethametsulfuron, Ethamet- sulfuron-Methyl, Ethiozin, Ethofumesate, Ethoxyfen, Ethoxyfen-Ethyl, Ethoxysulfuron, Etobenzanid, F- 5231, d.h. N-[2-Chlor-4-fluor-5-[4-(3-fluorpropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]- ethansulfonamid, F-7967, i.e. 3-[7-Chlor-5-fluor-2-(trifluormethyl)-1H-benzimidazol-4-yl]-1-methyl-6- (trifluormethyl)pyrimidin-2,4(1H,3H)-dion, Fenoxaprop, Fenoxaprop-P, Fenoxaprop-Ethyl, Fenoxaprop- P-Ethyl, Fenoxasulfone, Fenpyrazone, Fenquinotrione, Fentrazamid, Flamprop, Flamprop-Isoproyl, Flamprop-Methyl,Flamprop-M-Isopropyl, Flamprop-M-Methyl, Flazasulfuron, Florasulam, Florpyrauxifen, Florpyrauxifen-benzyl, Fluazifop, Fluazifop-Butyl, Fluazifop-Methyl, Fluazifop-P, Fluazifop-P-Butyl, Flucarbazone, Flucarbazone-Natrium, Flucetosulfuron, Fluchloralin, Flufenacet, Flufenpyr, Flufenpyr-Ethyl, Flumetsulam, Flumiclorac, Flumiclorac-Pentyl, Flumioxazin, Fluometuron, BCS231028 Ausland - 21 - Flurenol, Flurenol-Butyl, -Dimethylammonium und -Methyl, Fluoroglycofen, Fluoroglycofen-Ethyl, Flupropanat, Flupropanat-Natrium, Flupyrsulfuron, Flupyrsulfuron-Methyl, Flupyrsulfuron-Methyl- Natrium, Fluridon, Flurochloridon, Fluroxypyr, Fluroxypyr-Butometyl, Fluroxypyr-Meptyl, Flurtamon, Fluthiacet, Fluthiacet-Methyl, Fomesafen, Fomesafen-Natrium, Foramsulfuron, Foramsulfuron-Natrium, Fosamine, Fosamine-Ammonium, Glufosinat, Glufosinat-Ammonium, Glufosinat-Natrium, L- Glufosinat-Ammonium, L-Glufosinat-Natrium, Glufosinat-P-Natrium, Glufosinat-P-Ammonium, Glyphosat, Glyphosat-Ammonium,Glyphosat-Isopropylammonium, Glyphosat-Diammonium, Glyphosat-Dimethylammonium, Glyphosat-Kalium, Glyphosat-Natrium, Glyphosat-Sesquinatrium und Glyphosat-Trimesium, H-9201, d.h. O-(2,4-Dimethyl-6-nitrophenyl)-O-ethyl- isopropylphosphoramidothioat, Halauxifen, Halauxifen-methyl, Halosafen, Halosulfuron, Halosulfuron- Methyl, Haloxyfop, Haloxyfop-P, Haloxyfop-Ethoxyethyl, Haloxyfop-P-Ethoxyethyl, Haloxyfop- Methyl, Haloxyfop-P-Methyl, Haloxifop-Natrium, Hexazinon, HNPC-A8169, i.e. Prop-2-yn-1-yl (2S)-2- {3-[(5-tert-butylpyridin-2-yl)oxy]phenoxy}propanoat, HW-02, d.h. 1-(Dimethoxyphosphoryl)-ethyl- (2,4-dichlorphenoxy)acetat, Hydantocidin, Icafolin, Icafolin-Methyl, Imazamethabenz, Imazamethabenz- Methyl, Imazamox, Imazamox-Ammonium, Imazapic, Imazapic-Ammonium, Imazapyr, Imazapyr- Isopropylammonium, Imazaquin, Imazaquin-Ammonium, Imazaquin-Methyl, Imazethapyr, Imazethapyr- Ammonium, Imazosulfuron, Indanofan, Indaziflam, Indolauxipyr, Iodosulfuron, Iodosulfuron-Methyl,Iodosulfuron-Methyl-Natrium, Ioxynil, Ioxynil-Lithium, -Octanoat, -Kalium und Natrium, Ipfencarbazon, Iptriazopyrid, i.e. 3-[(Isopropylsulfonyl)methyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5- (trifluormethyl)[1,2,4]triazolo-[4,3-a]pyridin-8-carboxamid, Isoproturon, Isouron, Isoxaben, Isoxaflutole, Karbutilat, KUH-043, d.h. 3-({[5-(Difluormethyl)-1-methyl-3-(trifluormethyl)-1H-pyrazol-4- yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazol, Ketospiradox, Ketospiradox-Kalium, Lactofen, Lenacil, Linuron, MCPA, MCPA-Butotyl, -Butyl, -Dimethylammonium, -Diolamin, -2- Ethylhexyl, -Ethyl, -Isobutyl, Isoctyl, -Isopropyl, -Isopropylammonium, -Methyl, Olamin, -Kalium, – Natrium und -Trolamin, MCPB, MCPB-Methyl, -Ethyl und -Natrium, Mecoprop, Mecoprop-Butotyl, Mecoprop- dimethylammonium, Mecoprop-Diolamin, Mecoprop-Etexyl, Mecoprop-Ethadyl, Mecoprop- Isoctyl, Mecoprop-Methyl, Mecoprop-Kalium, Mecoprop-Natrium, und Mecoprop-Trolamin, Mecoprop- P, Mecoprop-P-Butotyl, -Dimethylammonium,-2-Ethylhexyl und -Kalium, Mefenacet, Mefluidid, Mefluidid-Diolamin, Mefluidid-Kalium, Mesosulfuron, Mesosulfuron-Methyl, Mesosulfuron-Natrium, Mesotrion, Methabenzthiazuron, Metam, Metamifop, Metamitron, Metazachlor, Metazosulfuron, Methabenzthiazuron, Methiopyrsulfuron, Methiozolin, Methyl isothiocyanat, Metobromuron, Metolachlor, S-Metolachlor, Metosulam, Metoxuron, Metproxybicyclon, Metribuzin, Metsulfuron, Metsulfuron-Methyl, Molinat, Monolinuron, Monosulfuron, Monosulfuron-Methyl, MT-5950, d.h. N-[3- Chlor-4-(1-methylethyl)-phenyl]-2-methylpentanamid, NGGC-011, Napropamid, NC-310, i.e. 4-(2,4- Dichlorbenzoyl)-1-methyl-5-benzyloxypyrazol, Neburon, Nicosulfuron, Nonansäure (Pelargonsäure), Norflurazon, Ölsäure (Fettsäuren), Orbencarb, Orthosulfamuron, Oryzalin, Oxadiargyl, Oxadiazon, Oxasulfuron, Oxaziclomefone, Oxyfluorfen, Paraquat, Paraquat-dichlorid, Paraquat-Dimethylsulfat, Pebulat, Pendimethalin, Penoxsulam, Pentachlorphenol, Pentoxazon, Pethoxamid, Petroleumöl,BCS231028 Ausland - 22 - Phenmedipham, Phenmedipham-Ethyl, Picloram, Picloram-dimethylammonium, Picloram-Etexyl, Picloram-Isoctyl, Picloram-Methyl, Picloram-Olamin, Picloram-Kalium, Picloram-Triethylammonium, Picloram-Tripromin, Picloram-Trolamin, Picolinafen, Pinoxaden, Piperophos, Pretilachlor, Primisulfuron, Primisulfuron-Methyl, Prodiamine, Profoxydim, Prometon, Prometryn, Propachlor, Propanil, Propaquizafop, Propazine, Propham, Propisochlor, Propoxycarbazone, Propoxycarbazone- Natrium, Propyrisulfuron, Propyzamid, Prosulfocarb, Prosulfuron, Pyraclonil, Pyraflufen, Pyraflufen- Ethyl, Pyraquinat, Pyrasulfotol, Pyrazolynat (Pyrazolat), Pyrazosulfuron, Pyrazosulfuron-Ethyl, Pyrazoxyfen, Pyribambenz, Pyribambenz-Isopropyl, Pyribambenz-Propyl, Pyribenzoxim, Pyributicarb, Pyridafol, Pyridat, Pyriftalid, Pyriminobac, Pyriminobac-Methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac- Natrium, Pyroxasulfon, Pyroxsulam, Quinclorac, Quinclorac-Dimethylammonium, Quinclorac-Methyl, Quinmerac,Quinoclamin, Quizalofop, Quizalofop-Ethyl, Quizalofop-P, Quizalofop-P-Ethyl, Quizalofop- P-Tefuryl, QYM201, i.e.1-{2-Chlor-3-[(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]- 6-(trifluormethyl)phe-nyl}piperidin-2-on, Rimisoxafen, Rimsulfuron, Saflufenacil, Sethoxydim, Siduron, Simazine, Simetryn, SL-261, Sulcotrione, Sulfentrazone, Sulfometuron, Sulfometuron-Methyl, Sulfosulfuron, , SYP-249, d.h. 1-Ethoxy-3-methyl-1-oxobut-3-en-2-yl-5-[2-chlor-4- (trifluormethyl)phenoxy]-2-nitrobenzoat, SYP-300, i.e.1-[7-Fluor-3-oxo-4-(prop-2-in-1-yl)-3,4-dihydro- 2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidin-4,5-dion, 2,3,6-TBA, TCA (Trichloressigsäure) und seine Salze, z.B. TCA-ammonium, TCA-Calcium, TCA-Ethyl, TCA-Magnesium, TCA-Natrium, Tebuthiuron, Tefuryltrione, Tembotrion, Tepraloxydim, Terbacil, Terbucarb, Terbumeton, Terbuthylazine, Terbutryn, Tetflupyrolimet, Thaxtomin, Thenylchlor, Thiazopyr, Thiencarbazone, Thiencarbazon-Methyl, Thifensulfuron, Thifensulfuron-Methyl,Thiobencarb, Tiafenacil, Tolpyralat, Topramezon, Tralkoxydim, Triafamon, Tri-allat, Triasulfuron, Triaziflam, Tribenuron, Tribenuron- Methyl, Triclopyr, Triclopyr-Butotyl, Triclopyr-Cholin, Triclopyr-Ethyl, Triclopyr-Triethylammonium, Trietazine, Trifloxysulfuron, Trifloxysulfuron-Natrium, Trifludimoxazin, Trifluralin, Triflusulfuron, Triflusulfuron-Methyl, Tritosulfuron, Harnstoffsulfat, Vernolat, XDE-848, ZJ-0862, d.h.3,4-Dichlor-N- {2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}anilin, 3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4- trifluormethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazol-5- carbonsäuremethylester, 3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4-trifluormethyl-3,6- dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazol-5-carbonsäureethylester, 3-(2-Chlor- 4-fluor-5-(3-methyl-2,6-dioxo-4-trifluormethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5- dihydroisoxazol-5-carbonsäure, Ethyl-[(3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluormethyl)- 3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetat, 3-Chlor-2-[3- (difluormethyl)isoxazolyl-5-yl]phenyl-5-chlorpyrimidin-2-ylether, 2-(3,4-Dimethoxyphenyl)-4-[(2- hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-6-methylpyridazin-3(2H)-on, 2-({2-[(2- Methoxyethoxy)methyl]-6-methylpyridin-3-yl}carbonyl)cyclohexane-1,3-dion, (5-Hydroxy-1-methyl- 1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)methanon, 1-Methyl-4- [(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-yl propan-1- sulfonat, 4-{2-Chlor-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1-methyl- BCS231028 Ausland - 23 - 1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol-4-carboxylat; Cyanomethyl-4-amino-3-chlor-5-fluor-6-(7- fluor-1H-indol-6-yl)pyridin-2-carboxylat, Prop-2-yn-1-yl 4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol- 6-yl)pyridin-2-carboxylat,Methyl-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Benzyl-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Ethyl-4- amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor- 6-(7-fluor-1-isobutyryl-1H-indol-6-yl)pyridin-2-carboxylat, Methyl 6-(1-acetyl-7-fluor-1H-indol-6-yl)- 4-amino-3-chlor-5-fluorpyridin-2-carboxylat, Methyl-4-amino-3-chlor-6-[1-(2,2-dimethylpropanoyl)-7- fluor-1H-indol-6-yl]-5-fluorpyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor-6-[7-fluor-1- (methoxyacetyl)-1H-indol-6-yl]pyridin-2-carboxylat, Kalium 4-amino-3-chlor-5-fluor-6-(7-fluor-1H- indol-6-yl)pyridin-2-carboxylat, Natrium-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Butyl-4-amino-3-chlor-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridin-2-carboxylat, 4-Hydroxy- 1-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-on, 3-(5-tert-butyl-1,2-oxazol-3-yl)-4- hydroxy-1-methylimidazolidin-2-on,3-[5-Chloro-4-(trifluoromethyl)pyridin-2-yl]-4-hydroxy-1-methylimidazolidin-2-one, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 6-[(2-Hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2-methylphenyl)quinazoline-2,4(1H,3H)-dione, 3-(2,6-Dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en- 1-yl)carbonyl]-1-methylquinazoline-2,4(1H,3H)-dione, 2-[2-chloro-4-(methylsulfonyl)-3-(morpholine-4- ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-one, 1-(2-carboxyethyl)-4-(pyrimidin-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(pyridazin-3-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 4-(pyrimidin-2-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 4-(pyridazin-3-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate),1-(2-Carboxyethyl)-4-(1,3-thiazol-2- yl)pyridazin-1-iumsalz (mit passenden Anionen wie z.B Chlorid, Acetat oder Trifluoracetat), 1-(2- Carboxyethyl)-4-(1,3,4-thiadiazol-2-yl)pyridazin-1-iumsalz (mit passenden Anionen wie z.B Chlorid, Acetat oder Trifluoracetat), Methyl (2R)-2-{[(E)-({2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4- (trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methyliden)amino]oxy}propanoat, Methyl (2S)- 2-{[(E)-({2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenyl}methyliden)amino]oxy}propanoat, Methyl (2R / S)-2-{[(E)-({2-chlor-4-fluor-5-[3-methyl-2,6- dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methyliden)amino]oxy}propanoat, (E)- 2-(Trifluormethyl)benzaldehyd-O-{2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoyl}oxim, 2-Fluor- N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-[(R)-propylsulfinyl]-4-(trifluormethyl)benzamid, (2R)-2-[(4- Amino-3,5-dichlor-6-fluor-2-pyridyl)oxy]propancarbonsäure,2-Ethoxy-2-oxoethyl-1-{2-chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenoxy}cyclopropancarboxylat, 2-Methoxy-2-oxoethyl-1-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4- (trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}cyclopropancarboxylat, {[(1-{2-Chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenoxy}cyclopropyl)carbonyl]oxy}essigsäure, 2-(2-Brom-4-chlorbenzyl)-4,4-dimethyl-1,2- BCS231028 Ausland - 24 - oxazolidin-3-on, Methyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6- dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat, Ethyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat, Methyl-3-{2-chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}-6-methyl-3a,4,5,6- tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat, 3-{2-Chlor-4-fluor-5-[3-methyl-2,6-dioxo-4- (trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}-6-methyl-3a,4,5,6-tetrahydro-6aH- cyclopenta[d][1,2]oxazol-6a-carbonsäure, 3-{2-Chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluormethyl)- 3,6-dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a- carbonsäure Abscisinsäure und verwandte Analoga [z.B. (2Z,4E)-5-[6-Ethynyl-1-hydroxy-2,6-dimethyl-4- oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-diensäure, methyl-(2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6- dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoat, (2Z,4E)-3-ethyl-5-(1-hydroxy-2,6,6- trimethyl-4-oxocyclohex-2-en-1-yl)penta-2,4-diensäure, (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4- oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-diensäure, methyl (2E,4E)-5-(1-hydroxy-2,6,6- trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoat, (2Z,4E)-5-(2-hydroxy-1,3-dimethyl-5-oxobicyclo[4.1.0]hept-3-en-2-yl)-3-methylpenta-2,4-dienoic acid], Acibenzolar, Acibenzolar-S-methyl, S-adenosylhomocysteine, Allantoin, 2-aminoethoxyvinylglycine (AVG), aminooxyacetic acid and related esters [e.g. (isopropylidene)-aminooxyacetic acid 2-(methoxy)-2-oxoethyl ester, (isopropylidene)-aminooxyacetic acid 2-(hexyloxy)-2-oxoethyl ester, (cyclohexylidene)-aminooxyacetic acid 2-(isopropyloxy)-2-oxoethyl ester], 1-aminocycloprop-1-ylcarboxylic acid N-methyl- 1-aminocyclopropyl-1-carboxylic acid, 1-aminocyclopropyl-1-carboxylic acid amide, substituted 1- Aminocyclopropyl-1-carboxylic acid derivatives as described in DE3335514, EP30287, DE2906507 or US5123951, 1-aminocyclopropyl-1-hydroxamic acid, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, bikinin, brassinolide, brassinolide-ethyl, L-canalin, catechin and catechins (e.g. (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol), chitooligosaccharides (CO; COs differ from LCOs in thatthat they lack the fatty acid side chain characteristic of LCOs. COs, sometimes referred to as N-acetylchitooligosaccharides, are also composed of GlcNAc units, but have side chains that distinguish them from chitin molecules [(C8H, 13 NO5) n , CAS No.1398-61-4] and chitosan molecules [(C5H 11 NO4) n, CAS No.9012-76-4]), chitin-like compounds, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, 1-[2-(4-cyano-3,5-dicyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-[2-(4-cyano-3-cyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-cyclopropenylmethanol, daminozide, dazomet, dazomet sodium, n-decanol, dikegulac, dikegulac sodium, endothal, endothal-di-potassium, -di-sodium, and mono(N,N-dimethylalkylammonium), ethephon, 1-ethylcyclopropene, flumetralin, flurenol, flurenol-butyl, flurenol-methyl, flurprimidol, forchlorfenuron, Gibberellic acid, inabenfid, indole-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, jasmonic acid esters or other derivatives (e.g. jasmonic acid methyl ester, jasmonic acid ethyl ester), BCS231028 Foreign countries - 25 - Lipochitooligosaccharides (LCO, in some cases also referred to as symbiotic nodulation signals (Nod or Nod factors) or as Myc factors,consist of an oligosaccharide backbone of β-l,4-linked -N-acetyl-D-glucosamine residues (“GlcNAc”) with an N-linked fatty acid side chain fused to the non-reducing end. As can be seen from the literature, LCOs differ in the number of GlcNAc units in the backbone structure, in the length and degree of saturation of the fatty acid chain as well as in the substitution of the reducing and non-reducing sugar units), linoleic acid or its derivatives, linolenic acid or its derivatives, maleic hydrazide, mepiquat chloride, mepiquat pentaborate, 1-methylcyclopropene, 3-methylcyclopropene, methoxyvinylglycine (MVG), 3'-methylabscisic acid, 1-(4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide and related substituted (tetrahydroquinolin-6-yl)methanesulfonamides, (3E,3aR,8bS)-3-({[(2R)-4-methyl-5-oxo-2,5- dihydrofuran-2-yl]oxy}methylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one and related lactones as described in EP2248421, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate mixture, 4-oxo-4[(2-phenylethyl)amino]butyric acid, paclobutrazol, 4-phenylbutyric acid and its salts (e.g. sodium 4-phenylbutanoate, potassium 4-phenylbutanoate), phenylalanine, N-phenylphthalamic acid, prohexadione, prohexadione calcium, 1-n-propylcyclopropene, putrescine, prohydrojasmone, rhizobitoxin, salicylic acid and salicyclic acid methyl ester, sarcosine, sodium cycloprop-1-en-1-yl acetate, sodium cycloprop-2-en-1-yl acetate, sodium 3-(cycloprop- 2-en-1-yl) propanoate, sodium 3-(cycloprop-1-en-1-yl) propanoate, sidefungin, spermidine, spermine, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tryptophan, tsitodef, uniconazole, uniconazole-P, 2-Fluoro-N-(3-methoxyphenyl)-9H-purine-6-amine,2-Chloro-N-(3-methoxyphenyl)-9H-purin-6-amine. The following safeners, for example, are also suitable as combination partners for the compounds of formula (I) according to the invention: S1) Compounds of formula (S1), O (R, A 1 ) nA where the symbols and indices have the following meanings: nA is a natural number from 0 to 5, preferably 0 to 3; RA 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; WA is an unsubstituted or substituted divalent heterocyclic radical from the group of partially saturated or aromatic five-membered ring heterocycles with 1 to 3 hetero ring atoms from the group BCS231028 Foreign countries - 26 - N and O, where at least one N atom and at most one O atom is contained in the ring, preferably a radical from the group (WA 1 ) to (WA 5 ), R 2 is ORA 3 , SRA of the NRA 3 R is a saturated or unsubstituted 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group O and S, which is bonded via the N atom to the carbonyl group in (S1) and is unsubstituted or substituted by radicals from the group (C1-C4)alkyl, (C1-C4)alkoxy or optionally substituted phenyl, preferably a radical of the formula ORA 3 , NHRA 4 or N(CH3)2, in particular of the formula ORA 3 ; RA 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably with a total of 1 to 18 C atoms; RA 4 is hydrogen, (C1-C6)alkyl, (C1-C6)alkoxy or substituted or unsubstituted phenyl; R A 5 is H, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy(C1-C8)alkyl, cyano or COOR A 9 , where RA 9is hydrogen, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C1-C6)hydroxyalkyl, (C3-C12)cycloalkyl or tri-(C1-C4)alkylsilyl; R.A 6 , Attorney 7 , Attorney 8 are identical or different and are hydrogen, (C1-C8)alkyl, (C1-C8)haloalkyl, (C3-C12)cycloalkyl or substituted or unsubstituted phenyl; R A 10 is H, (C3-C 12 )Cycloalkyl, substituted or unsubstituted phenyl or substituted or unsubstituted heteroaryl; preferably: a) compounds of the dichlorophenylpyrazolin-3-carboxylic acid type (S1 a ), preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid, 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid ethyl ester (S1-1) ("Mefenpyr-diethyl"), and related compounds as described in WO-A-91 / 07874; b) derivatives of dichlorophenylpyrazolecarboxylic acid (S1 b), preferably compounds such as 1-(2,4-dichlorophenyl)-5-methyl-pyrazole-3-carboxylic acid ethyl ester (S1-2), 1-(2,4-dichlorophenyl)-5-isopropyl-pyrazole-3-carboxylic acid ethyl ester (S1-3), 1-(2,4-dichloro- BCS231028 Ausland - 27 - phenyl)-5-(1,1-dimethyl-ethyl)pyrazole-3-carboxylic acid ethyl ester (S1-4) and related compounds as described in EP-A-333131 and EP-A-269806; c) derivatives of 1,5-diphenylpyrazole-3-carboxylic acid (S1 c ), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-5), methyl 1-(2-chlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-6) and related compounds as described, for example, in EP-A-268554; d) compounds of the triazolecarboxylic acid type (S1 d), preferably compounds such as fenchlorazole (ethyl ester), ie 1-(2,4-dichlorophenyl)-5-trichloromethyl-(1H)-1,2,4-triazole-3-carboxylic acid ethyl ester (S1-7), and related compounds as described in EP-A-174562 and EP-A-346620; e) compounds of the type 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1 e ), preferably compounds such as ethyl 5-(2,4-dichlorobenzyl)-2-isoxazoline-3-carboxylate (S1-8) or ethyl 5-phenyl-2-isoxazoline-3-carboxylate (S1-9) and related compounds as described in WO-A-91 / 08202, or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-10) or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-11) ("isoxadifen-ethyl") or -n-propyl ester (S1-12) or ethyl 5-(4-fluorophenyl)-5-phenyl-2-isoxazoline-3-carboxylate (S1-13) as described in patent application WO-A-95 / 07897. f) Compounds of the triazolyloxyacetic acid derivative type (S1 f), preferably compounds such as methyl {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-14) or {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-15) or methyl {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-16) or {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-17) or methyl {[1-(4- chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-18) or {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-19), as described in patent application WO2021 / 105101. S2) Quinoline derivatives of the formula (S2), n B where the symbols and indices have the following meanings: BCS231028 Foreign - 28 - RB 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; nB is a natural number from 0 to 5, preferably 0 to 3; RB 2 is ORB3 , SRB 3 or NRB 3 RB 4 or a saturated or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group O and S, which is bonded via the N atom to the carbonyl group in (S2) and is unsubstituted or substituted by radicals from the group (C1-C4)alkyl, (C1-C4)alkoxy or optionally substituted phenyl, preferably a radical of the formula ORB 3 , NHRB 4 or N(CH3)2, in particular of the formula ORB 3 ; RB 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably with a total of 1 to 18 C atoms; RB 4is hydrogen, (C1-C6)alkyl, (C1-C6)alkoxy or substituted or unsubstituted phenyl; TB is a (C1 or C2)-alkanediyl chain which is unsubstituted or substituted by one or two (C1-C4)alkyl radicals or by [(C1-C3)-alkoxy]carbonyl; preferably: a) compounds of the 8-quinolinoxyacetic acid type (S2 a), preferably (5-chloro-8-quinolinoxy)acetic acid (1-methylhexyl) ester ("Cloquintocet-mexyl") (S2-1), (5-chloro-8-quinolinoxy)acetic acid (1,3-dimethyl-but-1-yl) ester (S2-2), (5-chloro-8-quinolinoxy)acetic acid 4-allyloxy-butyl ester (S2-3), (5-chloro-8-quinolinoxy)acetic acid 1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinolinoxy)acetic acid ethyl ester (S2-5), (5-chloro-8-quinolinoxy)acetic acid methyl ester (S2-6), (5-chloro-8-quinolinoxy)acetic acid allyl ester (S2-7), (5-Chloro-8-quinolinoxy)acetic acid 2-(2-propylideneiminoxy)-1-ethyl ester (S2-8), (5-Chloro-8-quinolinoxy)acetic acid 2-oxo-prop-1-yl ester (S2-9) and related compounds as described in EP-A-86750, EP-A-94349 and EP-A-191736 or EP-A-0492366, and (5-Chloro-8-quinolinoxy)acetic acid (S2-10), their hydrates and salts, for example their lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium,or phosphonium salts as described in WO-A-2002 / 34048; b) compounds of the type (5-chloro-8-quinolinoxy)malonic acid (S2, b ), preferably compounds such as (5-chloro-8-quinolinoxy)malonic acid diethyl ester, (5-chloro-8-quinolinoxy)malonic acid diallyl ester, (5-chloro-8-quinolinoxy)malonic acid methyl ethyl ester and related compounds as described in EP-A-0582198. O R2 1 3) RD3 The (R The D 4 )mD BCS231028 Ausland - 30 - RD 1 ist CO-NRD 5 RD 6 oder NHCO-RD 7 ; RD 2 ist Halogen, (C1-C4)-Haloalkyl, (C1-C4)-Haloalkoxy, Nitro, (C1-C4)-Alkyl, (C1-C4)-Alkoxy, (C1- C4)-Alkylsulfonyl, (C1-C4)-Alkoxycarbonyl oder (C1-C4)-Alkylcarbonyl; RD 3 ist Wasserstoff, (C1-C4)Alkyl, (C2-C4)Alkenyl oder (C2-C4)-Alkinyl; RD 4is halogen, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, (C3-C6)-cycloalkyl, phenyl, (C1-C4)-alkoxy, cyano, (C1-C4)-alkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)alkylsulfonyl, (C1-C4)alkoxycarbonyl or (C1-C4)alkylcarbonyl; RD 5 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C5-C6)-cycloalkenyl, phenyl or 3- to 6-membered heterocyclyl containing vD heteroatoms from the group nitrogen, oxygen and sulfur, where the last seven radicals are substituted by vD substituents from the group halogen, (C1-C6)alkoxy, (C1-C6)haloalkoxy, (C1-C2)alkylsulfinyl, (C1-C2)alkylsulfonyl, (C3-C6)cycloalkyl, (C1-C4)alkoxycarbonyl, (C1-C4)alkylcarbonyl and phenyl and in the case of cyclic radicals also (C1-C4)alkyl and (C1-C4)haloalkyl; RD 6is hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl or (C2-C6)alkynyl, where the last three radicals are substituted by vD radicals from the group halogen, hydroxy, (C1-C4)alkyl, (C1-C4)alkoxy and (C1-C4)alkylthio, or RD 5 and RD 6 together with the nitrogen atom carrying them form a pyrrolidinyl or piperidinyl residue; RD 7 is hydrogen, (C1-C4)alkylamino, di-(C1-C4)alkylamino, (C1-C6)alkyl, (C3-C6)cycloalkyl, where the last two radicals are substituted by vD substituents from the group halogen, (C1-C4)alkoxy, (C1-C6)haloalkoxy and (C1-C4)alkylthio and, in the case of cyclic radicals, also (C1-C4)alkyl and (C1-C4)haloalkyl; nD is 0, 1 or 2; mD is 1 or 2; vD is 0, 1, 2 or 3; of these, preference is given to compounds of the N-acylsulfonamide type, e.g. of the following formula (S4 a ), which are known, for example, from WO-A-97 / 45016 OOO (R 4 D ) mD NN BCS231028 Foreign countries - 31 - where RD 7(C1-C6)alkyl, (C3-C6)cycloalkyl, where the last two radicals are substituted by vD substituents from the group halogen, (C1-C4)alkoxy, (C1-C6)haloalkoxy and (C1-C4)alkylthio and, in the case of cyclic radicals, also (C1-C4)alkyl and (C1-C4)haloalkyl; RD 4 Halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3; mD is 1 or 2; vD is 0, 1, 2 or 3; and acylsulfamoylbenzoic acid amides, e.g. of the following formula (S4 b ), which are known for example from WO-A-99 / 16744, R 5 D O O 4 e.g. those in which RD 5 = Cyclopropyl and (RD 4 ) = 2-OMe is ("Cyprosulfamide", S4-1), RD 5 = Cyclopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-2), RD 5 = Ethyl and (RD 4 ) = 2-OMe is (S4-3), R D 5 = Isopropyl and (R D 4 ) = 5-Cl-2-OMe is (S4-4) and R D 5 = Isopropyl and (R D 4) = 2-OMe (S4-5). as well as compounds of the N-acylsulfamoylphenylurea type of the formula (S4 c ), which are known for example from EP-A-365484, R 8 DOO O (R 4 D ) mD wherein RD 8 and RD 9 independently of one another hydrogen, (C1-C8)alkyl, (C3-C8)cycloalkyl, (C3-C6)alkenyl, (C3-C6)alkynyl, RD 4Halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3 BCS231028 Ausland - 32 - mD 1 or 2; for example 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea. S5) Active ingredients from the class of hydroxyaromatics and aromatic-aliphatic carboxylic acid derivatives (S5), e.g. ethyl 3,4,5-triacetoxybenzoate, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001. S6) Active ingredients from the class of 1,2-dihydroquinoxalin-2-ones (S6), e.g.1-Methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-thione, 1-(2-aminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one hydrochloride, 1-(2-methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, as described in WO-A-2005 / 112630. S7) Compounds of formula (S7) as described in WO-A-1998 / 38856 H2C A. E where the symbols and indices have the following meanings: RE 1 , RE 2 are independently halogen, (C1-C4)alkyl, (C1-C4)alkoxy, (C1-C4)haloalkyl, (C1-C4)alkylamino, di-(C1-C4)alkylamino, nitro; AE is COORE 3 or COSRE 4 RE 3 , RE 4 are independently hydrogen, (C1-C4)alkyl, (C2-C6)alkenyl, (C2-C4)alkynyl, cyanoalkyl, (C1-C4)haloalkyl, phenyl, nitrophenyl, benzyl, halobenzyl, pyridinylalkyl and alkylammonium, nE 1 is 0 or 1 nE 2 , nE 3are independently 0, 1 or 2, BCS231028 Ausland - 33 - preferably diphenylmethoxyacetic acid, ethyl diphenylmethoxyacetate, methyl diphenylmethoxyacetate (CAS Reg. No. 41858-19-9) (S7-1). S8) Compounds of the formula (S8), as described in WO-A-98 / 27049 R F 2 O Wherein XF CH or N, nF in case that XF=N, an integer from 0 to 4 and in case that XF=CH, an integer from 0 to 5 , RF 1 Halogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, nitro, (C1-C4)alkylthio, (C1-C4)alkylsulfonyl, (C1-C4)alkoxycarbonyl, optionally substituted. Phenyl, optionally substituted phenoxy, RF 2 Hydrogen or (C1-C4)alkyl RF 3hydrogen, (C1-C8)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, or aryl, where each of the abovementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy; or salts thereof, preferably compounds wherein XF is CH, nF is an integer from 0 to 2, RF 1 Halogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, RF 2 hydrogen or (C1-C4)alkyl, RF 3Hydrogen, (C1-C8)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, or aryl, where each of the aforementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy, or salts thereof. BCS231028 Foreign countries - 34 - S9) Active ingredients from the class of 3-(5-tetrazolylcarbonyl)-2-quinolones (S9), e.g. 1,2-dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 219479-18-2), 1,2-dihydro-4-hydroxy-1-methyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 95855-00-8), as described in WO-A-1999 / 000020. S10) Compounds of the formulas (S10 a ) or (S10 b ) as described in WO-A-2007 / 023719 and WO-A-2007 / 023764 OOZ 3 GR G 2 G where RG 1 Halogen, (C1-C4)alkyl, methoxy, nitro, cyano, CF3, OCF3 YG, ZG independently of one another are O or S, nG is an integer from 0 to 4, RG 2 (C1-C 16 )Alkyl, (C2-C6)Alkenyl, (C3-C6)Cycloalkyl, Aryl; Benzyl, Halogenbenzyl, R G 3hydrogen or (C1-C6)alkyl. S11) Active ingredients of the oxyimino compound type (S11), which are known as seed dressings, such as B. "Oxabetrinil" ((Z)-1,3-dioxolan-2-ylmethoxyimino(phenyl)acetonitrile) (S11-1), which is known as a seed dressing safener for millet against metolachlor damage, "Fluxofenim" (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethanone-O-(1,3-dioxolan-2-ylmethyl)-oxime) (S11-2), which is known as a seed dressing safener for millet against metolachlor damage, and "Cyometrinil" or "CGA-43089" ((Z)-cyanomethoxyimino(phenyl)acetonitrile) (S11-3), which is known as a seed dressing safener for millet against metolachlor damage. S12) Active ingredients from the class of isothiochromanones (S12), such as methyl [(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]acetate (CAS Reg. No. 205121-04-6) (S12-1) and related compounds from WO-A-1998 / 13361.S13) One or more compounds from group (S13): "Naphthalic anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), known as a seed dressing safener for maize against damage from thiocarbamate herbicides, "Fenclorim" (4,6-dichloro-2-phenylpyrimidine) (S13-2), known as a safener for pretilachlor in sown rice, "Flurazole" (benzyl 2-chloro-4-trifluoromethyl-1,3-thiazole-5-carboxylate) (S13-3), known as a seed dressing safener for millet against damage from alachlor and metolachlor, "CL 304415" (CAS Reg. No. 31541-57-8) (4-carboxy-3,4-dihydro-2H-1- benzopyran-4-acetic acid) (S13-4) from American Cyanamid, which is known as a safener for corn against damage from imidazolinones, "MG 191" (CAS Reg. No. 96420-72-3) (2-Dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as a safener for corn, "MG-838" (CAS Reg. No. 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) (S13-6) from Nitrokemia, "Disulfoton" (O,O-diethyl S-2-ethylthioethyl phosphodithioate) (S13-7), "Dietholate" (O,O-diethyl O-phenylphosphorothioate) (S13-8), "Mephenate" (4-chlorophenyl methylcarbamate) (S13-9). S14) Active ingredients that, in addition to herbicidal activity against harmful plants, also have a safener effect on crops such as rice, such as"Dimepiperate" or "MY-93" (S-1-methyl-1-phenylethyl-piperidine-1-carbothioate), known as a safener for rice against damage from the herbicide molinate, "Daimuron" or "SK 23" (1-(1-methyl-1-phenylethyl)-3-p-tolylurea), known as a safener for rice against damage from the herbicide imazosulfuron, "Cumyluron" = "JC-940" (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)urea, see JP-A-60087254), known as a safener for rice against damage from some herbicides, "Methoxyphenone" or "NK 049" (3,3'-dimethyl-4-methoxybenzophenone), known as a safener for rice against damage from some herbicides, "CSB" (1-Bromo-4-(chloromethylsulfonyl)benzene) from Kumiai, (CAS Reg. No. 54091-06-4), which is known as a safener against damage from some herbicides in rice. S15) Compounds of formula (S15) or their tautomers as described in WO-A-2008 / 131861 and WO-A-2008 / 131860 are OR 2 R 4 wherein. RH 1 a (C1-C6)haloalkyl radical and RH2 hydrogen or halogen and RH 3 , RH 4independently of one another are hydrogen, (C1-C16)alkyl, (C2-C16)alkenyl or (C2-C16)alkynyl, where each of the last-mentioned 3 radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3-C6)cycloalkyl which is unsubstituted or substituted, phenyl which is unsubstituted or substituted, and heterocyclyl which is unsubstituted or substituted, or (C3-C6)cycloalkyl, (C4-C6)cycloalkenyl, (C3- BCS231028 Ausland - 36 - C6)cycloalkyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)cycloalkenyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring,where each of the last-mentioned 4 radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3-C6)cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted, or RH, 3 (C1-C4)-alkoxy, (C2-C4)alkenyloxy, (C2-C6)alkynyloxy or (C2-C4)haloalkoxy and RH 4 hydrogen or (C1-C4)-alkyl or RH 3 and RH 4together with the directly bonded N atom forms a four- to eight-membered heterocyclic ring which, in addition to the N atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group N, O and S and which is unsubstituted or substituted by one or more radicals from the group halogen, cyano, nitro, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy and (C1-C4)alkylthio. S16) Active substances which are primarily used as herbicides but also have a safener effect on crops, e.g. (2,4-dichlorophenoxy)acetic acid (2,4-D), (4-chlorophenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (mecoprop), 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB), (4-chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-chloro-o-tolyloxy)butyric acid, 4-(4-chlorophenoxy)butyric acid, 3,6-dichloro-2-methoxybenzoic acid (dicamba), 1-(ethoxycarbonyl)ethyl 3,6-dichloro-2-methoxybenzoate (lactidichloroethyl).The following examples illustrate the invention. A. Chemical Examples Synthesis of 2-chloro-4-cyclopropyl-3-(S-methylsulfonimidoyl)-N-(1,3,4-oxadiazol-2-yl)benzamide (Table Example No. 1-4): To a solution of 266.9 mg (0.79 mmol) of 2-chloro-4-cyclopropyl-3-(methylsulfanyl)-N-(1,3,4-oxadiazol-2-yl)benzamide in 4 ml of methanol, 123.8 mg (1.58 mmol) of ammonium carbamate and, in portions, 638.3 mg (1.98 mmol) of iodosobenzene diacetate were added successively. The reaction mixture was stirred at room temperature for 20 hours and then largely freed of solvent on a rotary evaporator. After chromatographic purification of the residue, 106.7 mg (37.1%) of the desired product was obtained.Synthesis of 2-chloro-4-cyclopropyl-3-(methylsulfanyl)-N-(1,3,4-oxadiazol-2-yl)benzamide: 0.30 g (3.64 mmol) of 1-methyl-1H-imidazole was added to 0.50 g (1.82 mmol) of 2-chloro-4-cyclopropyl-3-(methylsulfanyl)benzoic acid, 0.17 g (2.00 mmol) of 1,3,4-oxadiazol-2-amine, and 3.0 ml of 3-methylpyridine, and the mixture was cooled to 0°C. At this temperature, 0.35 g (2.91 mmol) of thionyl chloride was added dropwise, the reaction mixture was allowed to warm slowly to room temperature, and stirred for 24 h at this temperature. For workup, saturated aqueous sodium chloride solution and dichloromethane were added, the organic phase was separated, and the solvent was removed under reduced pressure. After chromatographic purification of the residue, 267 mg (43.6%) of the desired product was obtained as a colorless solid. Synthesis of 2-methyl-3-(S-methylsulfonimidoyl)-N-(1,3,4-oxadiazol-2-yl)-4-(trifluoromethyl)benzamide (Table Example No. 1-2): To a solution of 130.0 mg (0.1%) ofTo a solution of 2-methyl-3-(methylsulfanyl)-N-(1,3,4-oxadiazol-2-yl)-4-(trifluoromethyl)benzamide (41 mmol) in 2 ml of methanol, 64.0 mg (0.82 mmol) of ammonium carbamate and 330.0 mg (1.02 mmol) of iodosobenzene diacetate were added successively. The reaction mixture was stirred at room temperature for 20 hours and then largely freed from solvent using a rotary evaporator. After chromatographic purification of the residue, 50.0 mg (33.3%) of the desired product was obtained. Synthesis of 4-(Difluoromethyl)-2-ethyl-3-(S-ethylsulfonimidoyl)-N-(1,3,4-oxadiazol-2-yl)benzamide (Table Example No. 1-6): 88.2 mg (1.13 mmol) of ammonium carbamate and 455 mg (1.41 mmol) of iodosobenzene diacetate were added successively to a solution of 185 mg (0.57 mmol) of 4-(difluoromethyl)-2-ethyl-3-(ethylsulfanyl)-N-(1,3,4-oxadiazol-2-yl)benzamide in 15 ml of methanol. The reaction mixture was then stirred at room temperature for 20 hours.For workup, a little water was added, followed by sodium bisulfite. The mixture was largely freed of solvent on a rotary evaporator. The residue was taken up with dichloromethane and a little water. After phase separation, the organic phase was freed of solvent on a rotary evaporator. The residue was purified by chromatography, yielding 25.2 mg of pure product. Synthesis of 4-(difluoromethyl)-2-ethyl-3-(ethylsulfanyl)-N-(1,3,4-oxadiazol-2-yl)benzamide: 634 mg (2.44 mmol) of 4-(difluoromethyl)-2-ethyl-3-(ethylsulfanyl)benzoic acid in 40 ml of dry tetrahydrofuran was heated to a temperature of 55 °C to 60 °C, then 592 mg (3.65 mmol) of 1,1'-carbonyldiimidazole was added portionwise. The reaction mixture was stirred under reflux for three hours. The contents were then cooled to room temperature, and 296 mg (1.83 mmol) of 1,1'-carbonyldiimidazole were added portionwise.The mixture was then stirred under reflux for a further four hours. In the next step, 327 mg (95 wt% purity; 3.65 mmol) of 1,3,4-oxadiazol-2-amine, 10 ml of acetonitrile, and 556 mg (3.65 mmol) of 1,8-diazabicyclo(5.4.0)undec-7-ene were added successively at room temperature. The contents of the flask were then stirred at room temperature for three days. To complete the reaction, the mixture was stirred at 50 °C for a further five hours, after which 164 mg (95 wt% purity; 1.83 mmol) of 1,3,4-oxadiazol-2-amine and 278 mg (1.83 mmol) of 1,8-diazabicyclo(5.4.0)undec-7-ene were added. The contents were stirred at room temperature for a further two days. For workup, the contents were largely freed of solvent using a rotary evaporator. The residue was treated with water and dichloromethane. After phase separation, the aqueous phase was adjusted to pH 3 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane.The combined organic phases were then freed from solvent using a rotary evaporator. The residue was purified by chromatography, yielding 505 mg of pure product. The examples listed in the following tables were prepared analogously to the methods mentioned above or are available analogously to the methods mentioned above. h. The compounds listed in the table below are particularly preferred. The abbreviations used mean: Me = Methyl Et = Ethyl c-Pr = Cyclopropyl Table 1: Compounds according to the invention of the general formula (I), wherein R', R'', and W each denote hydrogen Nr. X 1-1 Cl CHF2 Me Racemat 1-2 Me CF3 Me Racemat 1-3 Me CHF2 Me Racemat 1-4 Cl c-Pr Me Racemat BCS231028 Ausland - 39 - Nr.X Z R Bemerkung 1-5 Et CF3Me Racemat 1-6 Et CHF2 Et Racemat 1-7 Cl CF3 Me Racemat 1-8 Cl CHF2 Me Enantiomer A 1-9 Cl CHF2 Me Enantiomer B 1-10 c-Pr CHF2Me Racemat 1-11 Cl Me Me Racemat 1-12 c-Pr Cl Me Racemat 1-13 OMe CHF2 Me Racemat 1-14 Cl CF3Me Enantiomer A 1-15 Cl CF3 Me Enantiomer B 1-16 Me CHF2 Me Enantiomer A 1-17 Me CHF2 Me Enantiomer B 1-18 Me CF3 Me Enantiomer A 1-19 Me CF3 Me Enantiomer B 1-20 Me CHF2 Et Racemat 1-21 Me CHF2Et Enantiomer A 1-22 Me CHF2 Et Enantiomer B 1-23 Cl CHF2Et Racemat 1-24 Cl CHF2 Et Enantiomer A 1-25 Cl CHF2 Et Enantiomer B 1-26 Me CF3 Et Racemat 1-27 Me CF3 Et Enantiomer A 1-28 Me CF3 Et Enantiomer B 1-29 Cl CF3 Et Racemat 1-30 Cl CF3Et Enantiomer A 1-31 Cl CF3 Et Enantiomer B 1-32 Cl c-Pr Me Enantiomer A 1-33 Cl c-Pr Me Enantiomer B 1-34 Cl OCF3Me Racemat 1-35 Cl OCF3 Me Enantiomer A 1-36 Cl OCF3 Me Enantiomer B NMR-Daten ausgewählter Beispiele: Die. 1H-NMR data of selected examples of compounds of general formula (I) are presented in two different ways, namely (a) classical NMR evaluation and interpretation or (b) in the form of 1 H-NMR peak lists according to the method described below. a) Classical NMR interpretation BCS231028 Ausland - 40 - Ex. 1-10: 1 H-NMR (DMSO-D6, ^, ppm): 12.26 (bs, 1H), 9.08 (s, 1H), 7.93 (t, 1H), 7.83-7.79 (m, 2H), 4.89 (s, 1H), 3.42 (s, 3H), 2.63-2.61 (m, 1H), 1.03-0.95 (m, 2H), 0.76-0.74 (m, 1H), 0.61-0.58 (m, 1H). Ex.1-11: 1 H NMR (DMSO-D6, ^, ppm): 12.44 (bs, 1H), 9.05 (s, 1H), 7.66 (d, 1H), 7.45 (d, 1H), 4.83 (s, 1H), 3.30 (s, 3H), 2.76 (s, 3H). Examples 1-12: 1 H-NMR (DMSO-D6, ^, ppm): 12.23 (bs, 1H), 9.06 (s, 1H), 7.62-7.59 (m, 2H), 4.74 (s, 1H), 3.39 (s, 3H), 2.53-2.50 (m, 1H), 0.97-0.93 (m, 2H), 0.66-0.63 (m, 1H), 0.57-0.54 (m, 1H). Ex.1-13: 1H NMR (DMSO-D6, ^, ppm): 12.42 (bs, 1H), 9.09 (s, 1H), 7.98 (d, 1H), 7.89 (t, 1H), 7.72 (d, 1H), 3.88 (s, 3H), 3.44 (s, 3H). Ex.1-34: 1 HNMR (CDCl3, ^, ppm): 8.17 (bs, 1H), 7.79 (d, 1H), 7.46-7.39 (m, 1H), 3.44 (s, 3H). b) NMR peak list method The 1 H-NMR data of selected examples are presented in the form of 1 H-NMR peak lists. For each signal peak, the ^-value in ppm is listed first, followed by the signal intensity in parentheses. The ^-value – signal intensity number pairs of different signal peaks are listed separated by semicolons. The peak list of an example therefore has the form: ^1(Intensity1 ) ; ^2(Intensity2);……..; ^ i (Intensity i ) ;……; ^ n (Intensity n) The intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. For broad signals, multiple peaks or the center of the signal and their relative intensity compared to the most intense signal in the spectrum can be shown. For calibration of the chemical shift of 1 For H-NMR spectra, we use tetramethylsilane and / or the chemical shift of the solvent, especially in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak may or may not appear in NMR peak lists. 1 H-NMR peaks are similar to the classical 1 H-NMR printouts and thus usually contain all peaks that are found in a classical NMR interpretation. In addition, they can be interpreted like classical 1H-NMR printouts show solvent signals, signals of stereoisomers of the target compounds, which are also the subject of the invention, and / or peaks of impurities. BCS231028 Foreign Countries - 41 - When specifying compound signals in the delta range of solvents and / or water, our lists of 1H NMR peaks show the usual solvent peaks, for example, peaks of DMSO in DMSO-D6 and the peak of water, which usually have a high average intensity. The peaks of stereoisomers of the target compounds and / or peaks of impurities usually have a lower average intensity than the peaks of the target compounds (e.g., with a purity of >90%). Such stereoisomers and / or impurities can be typical for the respective manufacturing process. Their peaks can thus help identify the reproduction of our manufacturing process based on "by-product fingerprints." An expert who calculates the peaks of the target compounds using known methods (MestreC, ACD simulation, but also empirically evaluated expected values) can isolate the peaks of the target compounds as needed, using additional intensity filters if necessary.This isolation would be similar to the peak picking involved in classical music. 1 H-NMR interpretation. Further details on 1 H-NMR peak lists can be found in Research Disclosure Database Number 564025. 1-1: 1 H-NMR(600.3 MHz, d6-DMSO): δ= 12.6091 (1.8); 9.0661 (5.8); 8.0900 (3.9); 7.9987 (10.5); 7.9878 (10.9); 7.9713 (15.3); 7.9577 (6.2); 7.9068 (4.6); 5.2141 (7.2); 3.7974 (0.8); 3.4166 (0.3); 3.3915 (50.0); 3.3718 (1.6); 3.3518 (0.8); 3.3097 (8.6); 3.2735 (0.4); 2.5033 (10.8); 2.5003 (14.7); 2.4975 (10.6); -0.0001 (4.6) 1-2: 1H-NMR(600.3 MHz, CDCl3): δ= 8.2639 (3.9); 7.8999 (0.5); 7.8493 (4.3); 7.8358 (6.0); 7.7704 (3.9); 7.7569 (2.8); 7.2651 (17.7); 5.3011 (28.2); 4.1930 (0.4); 4.1803 (0.6); 4.1673 (0.4); 4.0412 (0.3); 4.0282 (0.5); 4.0151 (0.3); 3.8851 (0.5); 3.3368 (0.4); 3.3192 (50.0); 3.3090 (1.6); 3.2878 (0.8); 2.9552 (1.1); 2.9309 (0.4); 2.9135 (35.1); 2.8892 (0.3); 2.8771 (0.3); 2.8680 (0.4); 2.8610 (1.0); 2.8368 (0.6); 2.3934 (0.4); 2.3805 (0.6); 2.3675 (0.4); 2.0080 (1.1); 1.6364 (2.4); 1.4268 (2.3); 1.4097 (0.3); 1.2918 (0.6); 1.2847 (0.6); 1.2555 (3.7); 0.8915 (0.4) 1; 0.8802 (0.8); 0.8682 (0.5); -0.0001 (8.7) 1-3: H-NMR(400.6 MHz, CDCl3): δ= 7.5185 (2.9); 7.2880 (2.0); 7.2601 (551.0); 6.9965 (3.0); 3.4205 (3.4); 2.9523 (3.8); 2.8974 (2.0); 1.5503 (16.0); 1.3323 (1.8); 1.2838 (2.6); 1.2548 (3.7); 0.1582 (1.6); 0.1457 (3.1); 0.0688 (1.3); 0.0278 (3.0); 0.0080 (23.2); -0.0002 (759.1); -0.0085 (21.5); - 0.149 14 (2.7) 1-4: H-NMR(400.6 MHz, CDCl3): δ= 8.2209 (3.1); 7.5995 (1.8); 7.5791 (2.0); 7.2632 (11.3); 7.1892 (2.0); 7.1687 (1.9); 5.3009 (12.4); 3.4512 (16.0); 3.1237 (0.9); 3.1097 (0.5); 3.1025 (0.5); 1.1696 (1.5); 1.1647 (1.1); 1.1553 (1.0); 1.1484 (1.6); 1.1341 (0.6); 0.8914 (0.7); 0.8806 (0.6); 0.8772 (0.6); 0.7734 (0.5); 0.7682 (0.5); 0.7591 (0.7); 0.7544 (0.6); 0.7446 (0.6); 0.7357 (0.5); -0.0002 (12.4); -0.0085 (0.6) 1-5:. 1 H-NMR(400.6 MHz, d6-DMSO): δ= 9.0510 (1.3); 7.9145 (0.9); 7.8809 (0.6); 3.2525 (2.2); 3.2492 (2.2); 2.5407 (2.3); 2.5105 (3.8); 2.5059 (8.2); 2.5013 (11.4); 2.4966 (7.9); 2.4920 (3.4); 2.0882 (0.5); 2.0857 (16.0); 1.2103 (0.7); 1.1921 (1.6); 1.1738 (0.6); -0.0002 (11.5) 1-6: 1H-NMR(400.6 MHz, CDCl3): δ= 8.1960 (2.3); 8.1348 (1.7); 7.9996 (2.0); 7.9948 (1.9); 7.9154 (2.3); 7.8951 (3.3); 7.8596 (1.9); 7.8045 (3.3); 7.7843 (2.3); 7.2623 (24.9); 3.5364 (1.0); 3.5183 (3.3); 3.5000 (3.4); 3.4816 (1.1); 3.4098 (0.6); 3.3934 (1.0); 3.3797 (1.2); 3.3750 (3.0); 3.3616 (3.0); 3.3564 (3.2); 3.3432 (3.0); 3.3380 (1.2); 3.3255 (1.2); 3.3084 (0.6); 1.4291 (7.4); 1.4107 (16.0); 1.3921 (7.3); 1.2605 (3.7); 1.2424 (7.8); 1.2241 (3.6); 0.0080 (0.8); -0.0002 (35.4); -0.0085 (1.1) 1-7: 1H-NMR(400.6 MHz, d6-DMSO): δ= 9.0729 (0.5); 8.0749 (1.0); 8.0337 (0.6); 3.3681 (3.0); 3.3198 (0.6); 2.5105 (3.6); 2.5059 (7.9); 2.5013 (10.9); 2.4967 (7.6); 2,492 11 (3.3); 2.0856 (16.0); -0.0002 (5.9) 1-8: H-NMR(400.6 MHz, d6-DMSO): δ= 12.6242 (0.6); 9.0671 (3.0); 8.1317 (1.6); 8.1244 (0.6); 8.1036 (0.8); 8.0046 (1.4); 7.9946 (3.8); 7.9845 (5.0); 7.9707 (6.1); 7.9502 (1.7); 7.8572 (1.9); 7.4646 (0.9); 5.2259 (3.0); 4.0952 (0.6); 3.4270 (2.1); 3.4247 (2.0); 3.3909 (16.0); 3.3191 (5.8); 3.1711 (3.7); 3.1651 (3.7); 2.6744 (0.7); 2.6698 (0.9); 2.6652 (0.6); 2.5235 (2.4); 2.5189 (3.6); 2.5101 (51.8); 2.5056 (112.5); 2.5010 BCS231028 Foreign - 42 - (156.5); 2.4964 (107.2); 2.4918 (46.5); 2.4771 (0.5); 2.4721 (0.8); 2.4679 (0.9); 2.3327 (0.6); 2.3281 (0.9); 2.3234 (0.6); 1.0550 (0.6); 0.1459 (0.5); 0.0080 (5.2); -0.0002 (181.7); -0.0053 (1.3); -0.0062 (1.1); -0.0085 (4.9); -0.0285 (0.5); -0.0340 (0.5); -0.1492 (0.5) 1-9: 1H-NMR(400.6 MHz, d6-DMSO): δ= 9.0672 (1.9); 8.1316 (1.1); 8.0047 (1.0); 7.9944 (2.6); 7.9845 (3.7); 7.9708 (4.6); 7.9503 (1.3); 7.8571 (1.3); 5.2245 (2.0); 4.1088 (0.9); 4.0957 (2.7); 4.0827 (2.8); 4.0697 (1.0); 3.3914 (10.4); 3.3894 (10.2); 3.3198 (8.2); 3.1741 (16.0); 3.1615 (15.5); 2.6697 (0.5); 2.5235 (1.2); 2.5188 (1.7); 2.5101 (27.2); 2.5055 (60.0); 2.5009 (83.9); 2.4963 (57.6); 2.4917 (25.3); 1.0724 (0.6); 1.0550 (1.2); 1.0375 (0.6); 0.0080 (3.0); 0.0064 (0.9); 0.0055 (1.0); 0.0047 (1.3); 0.0038 (1.8); -0.0002 (97.4); -0.0026 (3.8); -0.0042 (1.3); -0.0051 (0.9); -0.0059 (0.7); -0.0067 (0.6); -0.0085 (2.6) B. Formulation examples a) A dust is obtained by mixing 10 parts by weight of a compound of the formula (I) and / or salts thereof and 90 parts by weight of talc as an inert substance and comminuting in a hammer mill.b) A wettable powder which is easily dispersible in water is obtained by mixing 25 parts by weight of a compound of formula (I) and / or salts thereof, 64 parts by weight of kaolin-containing quartz as inert substance, 10 parts by weight of potassium ligninsulfonate and 1 part by weight of sodium oleoylmethyltaurine as wetting and dispersing agent and grinding in a pin mill. c) A dispersion concentrate which is easily dispersible in water is obtained by mixing 20 parts by weight of a compound of formula (I) and / or salts thereof with 6 parts by weight of alkylphenol polyglycol ether (®Triton X 207), 3 parts by weight of isotridecanol polyglycol ether (8 EO) and 71 parts by weight of paraffinic mineral oil (boiling range, for example, approx. 255 to over 277°C) and grinding in a ball mill to a fineness of less than 5 microns. d) An emulsifiable concentrate is obtained from 15 parts by weight of a compound of formula (I) and / or salts thereof, 75 parts by weight of cyclohexanone as solvent and 10 parts by weight.-Parts of ethoxylated nonylphenol as an emulsifier. e) Water-dispersible granules are obtained by mixing 75 parts by weight of a compound of formula (I) and / or salts thereof, 10 parts by weight of calcium ligninsulfonate, 5 parts by weight of sodium lauryl sulfate, 3 parts by weight of polyvinyl alcohol, and 7 parts by weight of kaolin, grinding in a pin mill, and granulating the powder in a fluidized bed by spraying on water as the granulating liquid. f) A water-dispersible granulate is also obtained by mixing BCS231028 Ausland - 43 - 25 parts by weight of a compound of formula (I) and / or salts thereof, 5 parts by weight of 2,2'-dinaphthylmethane-6,6'-disulfonic acid sodium, 2 parts by weight of oleoylmethyltauric acid sodium, 1 part by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate and 50 parts by weight.-parts water in a colloid mill and pre-comminuted, then ground in a bead mill and the resulting suspension is atomized in a spray tower using a single-substance nozzle and dried. C. Biological Examples 1. Herbicidal Effect and Crop Compatibility During Post-Emergence Seeds of mono- and dicotyledonous weeds or cultivated plants were sown in plastic or wood fiber pots in sandy loam soil, covered with soil and grown in a greenhouse under controlled growth conditions. 2 to 3 weeks after sowing, the test plants were treated at the single-leaf stage. The compounds according to the invention, formulated in the form of wettable powders (WP) or as emulsion concentrates (EC), were then sprayed onto the green parts of the plant as an aqueous suspension or emulsion with the addition of 0.5% additive at a water application rate of the equivalent of 600 l / ha. After approx.After the test plants were kept in the greenhouse for 3 weeks under optimal growth conditions, the effectiveness of the preparations was visually assessed in comparison to untreated controls. For example, 100% effectiveness means plants died, 0% effectiveness means the same as the control plants. Tables A1 to A14 below show the effects of selected compounds of general formula (I) according to Table 1 on various weeds at application rates corresponding to 80 g / ha and lower, obtained according to the aforementioned test procedure. Appendices "a", "b", and "c" differentiate according to the dosages used for otherwise identically tested weeds.Table A1a: Post-emergence effect at 20 g / ha against ALOMY in % Example dosage number [g / ha] ALOMY 1-5 20 80 BCS231028 Abroad - 44 - Table A1b: Post-emergence effect at 80 g / ha against ALOMY in % Example dosage number [g / ha] ALOMY 1-4 80 80 1-6 80 80 1-3 80 90 1-8 80 80 1-34 80 80 Table A2a: Post-emergence effect at 5 g / ha against AMARE in % Example dosage number [g / ha] AMARE 1-5 5 90 1-2 5 90 1-11 5 80 1-1 5 100 1-10 5 90 Table A2b: Post-emergence effect at 20 g / ha against AMARE in % Example Dosage number [g / ha] AMARE 1-5 20 100 1-2 20 100 1-7 20 100 1-11 20 100 1-1 20 100 1-10 20 100 1-12 20 90 1-4 20 90 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100.

[0002] BCS231028 Foreign Countries - 45 - Table A2c: Post-emergence effect at 80 g / ha against AMARE in % Example Dosage number [g / ha] AMARE 1-4 80 90 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 Table A3a: Post-emergence effect at 20 g / ha against AVEFA in % Example Dosage number [g / ha] AVEFA 1-1 20 80 1-4 20 90 1-6 20 80 1-3 20 100 1-9 20 80 Table A3b: Post-emergence effect at 80 g / ha against AVEFA in % Example Dosage number [g / ha] AVEFA 1-4 80 100 1-6 80 80 1-3 80 100 1-9 80 100 1-8 80 90 1-34 80 90 Table A4a: Post-emergence effect at 5 g / ha against DIGSA in % Example Dosage number [g / ha] DIGSA 1-5 5 90 1-2 5 100 1-1 5 100 Table A4b: Post-emergence effect at 20 g / ha against DIGSA in % Example Dosage number [g / ha] DIGSA 1-5 20 90 BCS231028 Foreign countries - 46 - Example Dosage number [g / ha] DIGSA 1-2 20 100 1-7 20 100 1-11 20 100 1-1 20 100 1-10 20 90 1-4 20 90 1-6 20 90 1-3 20 100 1-9 20 90 1-8 20 90 Table A4c: Post-emergence effect at 80 g / ha against DIGSA in % Example Dosage number[g / ha] DIGSA 1-4 80 90 1-6 80 90 1-3 80 100 1-9 80 90 1-8 80 90 Table A5a: Post-emergence effect at 5 g / ha against ECHCG in % Example Dosage number [g / ha] ECHCG 1-5 5 90 Table A5b: Post-emergence effect at 20 g / ha against ECHCG in % Example Dosage number [g / ha] ECHCG 1-5 20 90 1-2 20 100 1-7 20 100 1-11 20 80 1-1 20 100 1-10 20 100 1-4 20 100 1-6 20 90 1-3 20 100 1-9 20 100 1-8 20 100 BCS231028 Foreign Countries - 47 - Table A5c: Post-emergence effect at 80 g / ha against ECHCG in % Example Dosage number [g / ha] ECHCG 1-4 80 100 Table A6a: Post-emergence effect at 20 g / ha against LOLRI in % Example Dosage number [g / ha] LOLRI 1-3 20 80 Table A6b: Post-emergence effect at 80 g / ha against LOLRI in % Example Dosage number [g / ha] LOLRI 1-4 80 90 1-6 80 80 1-3 80 100 1-9 80 90 1-8 80 90 Table A7a: Post-emergence effect at 5 g / ha against MATIN in % Example Dosage number [g / ha] MATIN 1-5 5 80 1-1 5 90 Table A7b: Post-emergence effect at 20 g / ha against MATIN in % Example Dosage number[g / ha] MATIN 1-5 20 80 1-2 20 100 1-7 20 90 1-1 20 100 1-10 20 80 1-4 20 90 1-6 20 90 1-3 20 100 1-9 20 90 1-8 20 100 1-34 20 100 BCS231028 Abroad - 48 - Table A7c: Post-emergence effect at 80 g / ha against MATIN in % Example Dosage number [g / ha] MATIN 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 90 1-8 80 100 1-34 80 100 Table A8a: Post-emergence effect at 5 g / ha against PHBPU in % Example Dosage number [g / ha] PHBPU 1-5 5 80 Table A8b: Post-emergence effect at 20 g / ha against PHBPU in % Example Dosage number [g / ha] PHBPU 1-5 20 90 1-2 20 100 1-7 20 90 1-1 20 90 1-4 20 90 1-6 20 90 1-3 20 100 1-9 20 80 1-8 20 100 Table A8c: Post-emergence effect at 80 g / ha against PHBPU in % Example Dosage number [g / ha] PHBPU 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 BCS231028 Foreign Countries - 49 - Table A9a: Post-emergence effect at 80 g / ha against POLCO in % Example Dosage number [g / ha] POLCO 1-4 80 100 1-6 80 80 1-3 80 80 1-9 80 90 1-8 80 90 Table A10a: Post-emergence effect at 5g / ha against SETVI in % Example Dosage number [g / ha] SETVI 1-5 5 90 1-1 5 90 Table A10b: Post-emergence effect at 20 g / ha against SETVI in % Example Dosage number [g / ha] SETVI 1-5 20 90 1-2 20 100 1-7 20 90 1-11 20 100 1-1 20 100 1-10 20 90 1-4 20 90 1-6 20 90 1-3 20 90 1-9 20 100 1-8 20 100 Table A10c: Post-emergence effect at 80 g / ha against SETVI in % Example Dosage number [g / ha] SETVI 1-4 80 90 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 BCS231028 Abroad - 50 - Table A11a: Post-emergence effect at 5 g / ha against VERPE in % Example Dosage number [g / ha] VERPE 1-5 5 80 1-2 5 90 1-7 5 90 1-11 5 80 1-1 5 90 Table A11b: Post-emergence effect at 20 g / ha against VERPE in % Example Dosage number [g / ha] VERPE 1-5 20 90 1-2 20 100 1-7 20 100 1-11 20 90 1-1 20 100 1-10 20 100 1-12 20 80 1-4 20 90 1-6 20 80 1-3 20 100 1-9 20 90 1-8 20 100 Table A11c: Post-emergence effect at 80 g / ha against VERPE in % Example Dosage number [g / ha] VERPE 1-4 80 100 1-6 80 90 1-3 80 100 1-9 80100 1-8 80 100 Table A12a: Post-emergence effect at 5 g / ha against VIOTR in % Example Dosage number [g / ha] VIOTR 1-5 5 90 1-2 5 100 1-7 5 100 1-11 5 90 BCS231028 Abroad - 51 - Example Dosage number [g / ha] VIOTR 1-1 5 100 1-10 5 100 Table A12b: Post-emergence effect at 20 g / ha against VIOTR in % Example Dosage number [g / ha] VIOTR 1-5 20 100 1-2 20 100 1-7 20 100 1-11 20 100 1-1 20 100 1-10 20 100 1-4 20 100 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 1-34 20 100 Table A12c: Post-emergence efficacy at 80 g / ha against VIOTR in % Example Dosage number [g / ha] VIOTR 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 1-34 80 100 Table A13a: Post-emergence efficacy at 5 g / ha against ABUTH in % Example Dosage number [g / ha] ABUTH 1-2 5 100 1-7 5 80 1-11 5 100 1-1 5 100 1-10 5 100 1-12 5 90 BCS231028 Abroad - 52 - Table A13b: Post-emergence effect at 20 g / ha against ABUTH in % Example Dosage number [g / ha] ABUTH 1-2 20 100 1-7 20 100 1-11 20 100 1-1 20 100 1-10 20 100 1-12 20100 1-4 20 90 1-6 20 90 1-3 20 100 1-9 20 100 1-8 20 100 Table A13c: Post-emergence effect at 80 g / ha against ABUTH in % Example Dosage number [g / ha] ABUTH 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 Table A14a: Post-emergence effect at 20 g / ha against KCHSC in % Example Dosage number [g / ha] KCHSC 1-4 20 90 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 Table A14b: Post-emergence effect at 80 g / ha against KCHSC in % Example Dosage number [g / ha] KCHSC 1-4 80 90 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 BCS231028 Abroad - 53 - Tables A15 to A19 below show the crop tolerances of selected compounds of the general formula (I) according to Table 1 at an application rate corresponding to 20 g / ha or lower, which were observed in tests carried out according to the aforementioned test procedure. The observed effects on selected crops are given in comparison with the untreated controls (values ​​in %).The appendices “a”, “b” and “c” differentiate according to the dosages used for otherwise identically tested crops. Table A15a: Post-emergence effect at 5g / ha against ZEAMX in % Example Dosage number [g / ha] ZEAMX 1-5 5 10 1-2 5 0 1-7 5 0 1-11 5 0 1-1 5 0 1-10 5 0 1-12 5 0 1-13 5 0 Table A15b: Post-emergence effect at 20g / ha against ZEAMX in % Example Dosage number [g / ha] ZEAMX 1-5 20 20 1-2 20 0 1-7 20 0 1-11 20 0 1-10 20 0 1-12 20 0 1-13 20 0 1-4 20 10 1-8 20 0 Table A16a: Post-emergence effect at 5g / ha against TRZAS in % Example Dosage number [g / ha] TRZAS 1-5 5 10 1-2 5 0 1-7 5 0 BCS231028 Abroad - 54 - 1-11 5 0 1-1 5 0 1-10 5 0 1-12 5 0 1-13 5 0 Table A16b: Post-emergence effect at 20g / ha against TRZAS in % Example Dosage number [g / ha] TRZAS 1-7 20 0 1-11 20 0 1-1 20 0 1-10 20 0 1-12 20 0 1-13 20 0 1-9 20 20 1-8 20 20 Table A17a: Post-emergence effect at 5g / ha against ORYSA in % Example Dosage number [g / ha] ORYSA 1-5 5 20 1-2 5 0 1-7 5 0 1-11 5 0 1-10 5 0 1-125 0 1-13 5 0 Table A17b: Post-emergence effect at 20g / ha against ORYSA in % Example Dosage number [g / ha] ORYSA 1-11 20 0 1-10 20 20 1-12 20 0 1-13 20 0 BCS231028 Foreign Countries - 55 - Table A18a: Post-emergence effect at 5g / ha against GLXMA in % Example Dosage number [g / ha] GLXMA 1-13 5 0 Table A18b: Post-emergence effect at 20g / ha against GLXMA in % Example Dosage number [g / ha] GLXMA 1-13 20 0 Table A19a: Post-emergence effect at 5g / ha against BRSNW in % Example Dosage number [g / ha] BRSNW 1-13 5 0 Table A19b: Post-emergence activity at 20 g / ha against BRSNW in % Example Dosage number [g / ha] BRSNW 1-13 20 0 As the results show, compounds of the general formula (I) according to the invention, when applied post-emergence, have good herbicidal activity against weeds such as, for example, Abutilon theophrasti (ABUTH), Alopecurus myosuroides (ALOMY), Amaranthus retroflexus (AMARE), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinochloa crus-galli (ECHCG), Kochia scoparia(KCHSC), Lolium rigidum (LOLRI), Matricaria inodora (MATIN), Pharbitis purpurea (PHBPU), Polygonum convolvulus (POLCO), Setaria viridis (SETVI), Veronica persica (VERPE) and Viola tricolor (VIOTR) at an application rate of 0.08 kg active ingredient or less per hectare, as well as good crop tolerance in organisms such as Oryza sativa (ORYSA), Zea mays (ZEAMX), Brassica napus (BRSNW), Glycine max (GLXMA) and Triticum aestivum (TRZAS) at an application rate of 0.02 kg or less per hectare. BCS231028 Foreign countries - 56 - 2. Herbicidal activity and crop tolerance in pre-emergence Seeds of monocotyledonous and dicotyledonous weeds and crops were sown in plastic or organic plant pots and covered with soil. The compounds according to the invention, formulated in the form of wettable powders (WP) or as emulsion concentrates (EC), were then applied as an aqueous suspension or emulsion with the addition of 0.5% additive at a water application rate of the equivalent of 600 l / haapplied to the surface of the covering soil. After treatment, the pots were placed in the greenhouse and kept under good growth conditions for the test plants. After approximately 3 weeks, the effect of the preparations was visually assessed in percentages compared to untreated controls. For example, 100% effect means plants have died, 0% effect = same as control plants. Tables B1 to B14 below show the effects of selected compounds of the general formula (I) according to Table 1 on various weeds and an application rate corresponding to 80 g / ha and lower, which were obtained according to the aforementioned test procedure. Appendices “a”, “b” and “c” differentiate according to the dosages used for otherwise identically tested weeds. Table B1a: Pre-emergence effect at 80 g / ha against ALOMY in % Example Dosage number [g / ha] ALOMY 1-5 80 90 1-2 80 80 1-6 80 90 1-3 80 80 1-34 80 80 Table B2a:Pre-emergence effect at 20 g / ha against AMARE in % Example Dosage number [g / ha] AMARE 1-5 20 100 1-2 20 100 1-11 20 90 1-1 20 100 1-10 20 80 1-4 20 90 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 BCS231028 Abroad - 57 - Table B2b: Pre-emergence effect at 80 g / ha against AMARE in % Example Dosage number [g / ha] AMARE 1-5 80 100 1-2 80 100 1-7 80 100 1-11 80 100 1-1 80 100 1-10 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 Table B3a: Pre-emergence effect at 20 g / ha against AVEFA in % Example Dosage number [g / ha] AVEFA 1-3 20 80 Table B3b: Pre-emergence effect at 80 g / ha against AVEFA in % Example Dosage number [g / ha] AVEFA 1-2 80 90 1-7 80 90 1-1 80 90 1-6 80 90 1-3 80 100 1-9 80 100 1-8 80 90 1-34 80 90

[0003] BCS231028 Foreign Countries - 58 - Table B4a: Pre-emergence effect at 20 g / ha against DIGSA in % Example Dosage number [g / ha] DIGSA 1-5 20 100 1-2 20 100 1-7 20 100 1-11 20 100 1-1 20 100 1-10 20 100 1-4 20 100 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 Table B4b: Pre-emergence effect at 80 g / ha against DIGSA in % Example Dosage number [g / ha] DIGSA 1-5 80 100 1-2 80 100 1-7 80 100 1-11 80 100 1-1 80 100 1-10 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 Table B5a: Pre-emergence effect at 20 g / ha against ECHCG in % Example Dosage number [g / ha] ECHCG 1-2 20 100 1-7 20 100 1-1 20 100 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 BCS231028 Abroad - 59 - Table B5b: Pre-emergence effect at 80 g / ha against ECHCG in % Example Dosage number [g / ha] ECHCG 1-5 80 100 1-2 80 100 1-7 80 100 1-11 80 100 1-1 80 100 1-10 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 Table B6a: Pre-emergence efficacy at 80 g / ha against LOLRI in % Example Dosage number [g / ha] LOLRI 1-680 80 1-3 80 90 1-8 80 80 Table B7a: Pre-emergence effect at 20 g / ha against MATIN in % Example Dosage number [g / ha] MATIN 1-5 20 90 1-2 20 100 1-7 20 100 1-1 20 100 1-4 20 90 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 1-34 20 100 BCS231028 Abroad - 60 - Table B7b: Pre-emergence effect at 80 g / ha against MATIN in % Example Dosage number [g / ha] MATIN 1-5 80 100 1-2 80 100 1-7 80 100 1-11 80 100 1-1 80 100 1-10 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 1-34 80 100 Table B8a: Pre-emergence effect at 20 g / ha against PHBPU in % Example Dosage number [g / ha] PHBPU 1-1 20 80 1-4 20 80 1-6 20 90 1-3 20 90 1-8 20 80 Table B8b: Pre-emergence effect at 80 g / ha against PHBPU in % Example Dosage number [g / ha] PHBPU 1-5 80 100 1-2 80 100 1-1 80 100 1-10 80 80 1-4 80 90 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 BCS231028 Abroad - 61 - Table B9a: Pre-emergence effect at 20 g / ha against POLCO in % Example Dosage number [g / ha] POLCO 1-6 20 80 Table B9b:Pre-emergence effect at 80 g / ha against POLCO in % Example Dosage number [g / ha] POLCO 1-7 80 80 1-11 80 100 1-1 80 90 1-10 80 90 1-6 80 90 1-3 80 90 Table B10a: Pre-emergence effect at 20 g / ha against SETVI in % Example Dosage number [g / ha] SETVI 1-5 20 90 1-2 20 100 1-1 20 100 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 Table B10b: Pre-emergence effect at 80 g / ha against SETVI in % Example Dosage number [g / ha] SETVI 1-5 80 100 1-2 80 100 1-7 80 100 1-11 80 90 1-1 80 100 1-10 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 BCS231028 Abroad - 62 - Table B11a: Pre-emergence effect at 20 g / ha against VERPE in % Example Dosage number [g / ha] VERPE 1-5 20 100 1-6 20 90 1-3 20 100 1-9 20 80 Table B11b: Pre-emergence effect at 80 g / ha against VERPE in % Example Dosage number [g / ha] VERPE 1-5 80 100 1-2 80 100 1-1 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 Table B12a: Pre-emergence effect at 20 g / ha against VIOTR in % Example Dosage number[g / ha] VIOTR 1-5 20 100 1-2 20 90 1-7 20 100 1-11 20 80 1-1 20 100 1-10 20 90 1-4 20 90 1-6 20 90 1-3 20 100 1-9 20 100 1-8 20 100 Table B12b: Pre-emergence effect at 80 g / ha against VIOTR in % Example Dosage number [g / ha] VIOTR 1-5 80 100 1-2 80 100 1-7 80 100 BCS231028 Abroad - 63 - Example Dosage number [g / ha] VIOTR 1-11 80 100 1-1 80 100 1-10 80 100 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 1-34 80 100 Table B13a: Pre-emergence effect at 20 g / ha against ABUTH in % Example Dosage number [g / ha] ABUTH 1-5 20 100 1-2 20 100 1-7 20 100 1-11 20 100 1-1 20 100 1-10 20 100 1-4 20 90 1-6 20 100 1-3 20 100 1-9 20 100 1-8 20 100 Table B13b: Pre-emergence effect at 80 g / ha against ABUTH in % Example Dosage number [g / ha] ABUTH 1-5 80 100 1-2 80 100 1-7 80 100 1-11 80 100 1-1 80 100 1-10 80 100 1-12 80 90 1-4 80 100 1-6 80 100 1-3 80 100 1-9 80 100 1-8 80 100 BCS231028 Abroad - 64 - Table B14a: Pre-emergence effect at 20 g / ha against KCHSC in % Example DosageTables B15 to B19 below show the crop tolerances of selected compounds of the general formula (I) according to Table 1 at an application rate corresponding to 80 g / ha or lower, as observed in trials carried out in accordance with the aforementioned test procedure. The effects observed on selected crops are given in comparison to the untreated controls (values ​​in %). Appendices "a", "b", and "c" differentiate according to the dosages used for otherwise identically tested crops. Table B15a: Pre-emergence effect at 20 g / ha against ZEAMX in % Example Dosage Number [g / ha] ZEAMX 1-5 20 0 1-2 20 0 1-7 20 0 1-11 20 0 1-1 20 0 1-10 20 0 1-12 20 0 1-13 20 0 1-9 20 0 1-8 20 0 BCS231028Abroad - 65 - Table B15b: Pre-emergence effect at 80 / ha against ZEAMX in % Example Dosage number [g / ha] ZEAMX 1-5 80 0 1-2 80 0 1-7 80 0 1-11 80 0 1-1 80 0 1-10 80 0 1-12 80 0 1-13 80 0 1-4 80 10 1-9 80 0 1-8 80 20 Table B16a: Pre-emergence effect at 20g / ha against TRZAS in % Example Dosage number [g / ha] TRZAS 1-5 20 10 1-11 20 0 1-10 20 0 1-12 20 0 1-13 20 0 1-4 20 0 1-9 20 0 1-34 20 10 Table B16b: Pre-emergence effect at 80g / ha against TRZAS in % Example Dosage number [g / ha] TRZAS 1-10 80 0 1-12 80 0 1-13 80 0 BCS231028 Foreign Countries - 66 - Table B17a: Pre-emergence effect at 20g / ha against ORYSA in % Example Dosage number [g / ha] ORYSA 1-5 20 20 1-12 20 0 1-13 20 0 Table B18a: Pre-emergence effect at 20g / ha against GLXMA in % Example Dosage number [g / ha] GLXMA 1-13 20 0 1-4 20 10 Table B18b: Pre-emergence effect at 80g / ha against GLXMA in % Example- Dosage number [g / ha] GLXMA 1-13 80 0 Table B19a: Pre-emergence effect at 20g / ha against BRSNW in % Example Dosage number[g / ha] BRSNW 1-12 20 0 1-13 20 0 Table B19b: Pre-emergence activity at 80 g / ha against BRSNW in % Example Dosage number [g / ha] BRSNW 1-13 80 0 BCS231028 Abroad - 67 - As the results show, compounds of the general formula (I) according to the invention have good herbicidal activity against weeds such as, for example, B. Abutilon theophrasti (ABUTH), Alopecurus myosuroides (ALOMY), Amaranthus retroflexus (AMARE), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinochloa crus-galli (ECHCG), Kochia scoparia (KCHSC), Lolium rigidum (LOLRI), Matricaria inodora (MATIN), Pharbitis purpurea (PHBPU), Polygonum convolvulus (POLCO), Setaria viridis (SETVI), Veronica persica (VERPE) and Viola tricolor (VIOTR) at an application rate of 0.08 kg active ingredient or less per hectare, as well as good crop tolerance in organisms such as Oryza sativa (ORYSA), Zea mays (ZEAMX), Brassica napus (BRSNW), Glycine max (GLXMA) and Triticum aestivum(TRZAS) at an application rate of 0.08 kg or less per hectare. 3. Comparative herbicidal activity and crop plant tolerance of compounds of the invention with known, structurally similar compounds from WO2013 / 124228 in post- and pre-emergence. Table C1 below compares the compounds of the invention and the known, structurally similar compounds from WO2013 / 124228. The compounds of the invention differ from the known compounds in a significant structural feature. In contrast to the known compounds from the literature, the compounds of the invention (1-1, 1-2, 1-7, 1-11, 1-13) do not bear a methyl substituent on the oxadiazole ring. Table C1 Compound according to the invention Structurally similar compound from WO2013 / 124228 1-1 (according to the invention) *7-18 (WO2013 / 124228) *1-2 (according to the invention) *7-6 (WO2013 / 124228)* 1-7 (according to the invention) *7-17 (WO2013 / 124228) *1-11 (according to the invention) *7-12(WO2013 / 124228) *1-13 (according to the invention) *7-29 (WO2013 / 124228) *The following Tables C2-C11 show the post-emergence effects on various weeds of compounds according to the invention and of a structurally similar compound known from the literature from BCS231028 Ausland - 68 - WO2013 / 124228 at an application rate corresponding to 20 g / ha and lower, which were obtained according to the test procedure mentioned above. Table C2 Compound ABUTH Application rate (effect in %) [g / ha] 1-11 (according to the invention) 100 5 7-12 (WO2013 / 124228) 0 5 Table C3 Compound AMARE Application rate (effect in %) [g / ha] 1-11 (according to the invention) 100 20 7-12 (WO2013 / 124228) 60 20 1-2 (according to the invention) 90 5 7-6 (WO2013 / 124228) 40 5 Table C4 Compound AVEFA Application rate (effect in %) [g / ha] 1-1 (according to the invention) 80 20 7-18 (WO2013 / 124228) 30 20 Table C5 Compound DIGSA Application rate (effect in %) [g / ha] 1-1 (according to the invention) 100 5 7-18 (WO2013 / 124228) 70 5 1-11 (according to the invention) 100 20 7-12 (WO2013 / 124228) 80 20 BCS231028 Foreign countries - 69 - Table C6 Compound ECHCGApplication rate (effect in %) [g / ha] 1-11 (according to the invention) 80 20 7-12 (WO2013 / 124228) 0 20 Table C7 Compound MATIN Application rate (effect in %) [g / ha] 1-1 (according to the invention) 90 5 7-18 (WO2013 / 124228) 70 5 1-2 (according to the invention) 100 20 7-6 (WO2013 / 124228) 70 20 Table C8 Compound PHPBU Application rate (effect in %) [g / ha] 1-11 (according to the invention) 90 20 7-12 (WO2013 / 124228) 70 20 Table C9 Compound SETVI Application rate (effect in %) [g / ha] 1-1 (according to the invention) 90 5 7-18 (WO2013 / 124228) 70 5 1-11 (according to the invention) 100 20 7-12 (WO2013 / 124228) 0 20 BCS231028 Abroad - 70 - Table C10 Compound VERPE Application rate (effect in %) [g / ha] 1-1 (according to the invention) 90 5 7-18 (WO2013 / 124228) 70 5 1-2 (according to the invention) 90 5 7-6 (WO2013 / 124228) 70 5 1-11 (according to the invention) 80 5 7-12 (WO2013 / 124228) 0 5 Table C11 Compound VIOTR Application rate (effect in %) [g / ha] 1-1 (according to the invention) 100 5 7-18 (WO2013 / 124228) 70 5 1-2 (according to the invention) 100 5 7-6 (WO2013 / 124228) 80 5 1-7 (according to the invention) 100 57-17 (WO2013 / 124228) 70 5 1-11 (according to the invention) 90 5 7-12 (WO2013 / 124228) 50 5 As the results shown in Tables C2 to C11 show, compounds according to the invention (1-1, 1-2, 1-7, 1-11) have a significantly improved post-emergence herbicidal activity against weeds such as Abutilon theophrasti (ABUTH), Amaranthus retroflexus (AMARE), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinochloa crus-galli (ECHCG), Matricaria inodora (MATIN), Pharbitis purpurea (PHBPU), Setaria viridis (SETVI), Veronica persica (VERPE), and Viola tricolor (VIOTR) at an application rate of 20 g of active ingredient or less per hectare. Tables C12-C16 below show the post-emergence crop tolerance of compounds according to the invention and the literature-known structurally similar compound from WO2013 / 124228 at an application rate corresponding to 20 g / ha.and lower, obtained according to the previously mentioned experimental procedure. BCS231028 Foreign Countries - 71 - Table C12 Compound BRSNW Application rate (effect in %) [g / ha] 1-13 (according to the invention) 0 20 7-29 (WO2013 / 124228) 80 20 Table C13 Compound GLXMA Application rate (effect in %) [g / ha] 1-13 (according to the invention) 0 20 7-29 (WO2013 / 124228) 80 20 Table C14 Compound ORYSA Application rate (effect in %) [g / ha] 1-7 (according to the invention) 0 5 7-17 (WO2013 / 124228) 30 5 Table C15 Compound TRZAS Application rate (effect in %) [g / ha] 1-7 (according to the invention) 0 20 7-17 (WO2013 / 124228) 60 20 Table C16 Compound ZEAMX Application rate (effect in %) [g / ha] 1-7 (according to the invention) 0 20 7-17 (WO2013 / 124228) 20 20 1-13 (according to the invention) 0 20 7-29 (WO2013 / 124228) 20 20 BCS231028 Foreign countries - 72 - As the results presented in Tables C12 to C16 show, compounds according to the invention (1-7, 1-13) have, in comparison to the structurally similar compounds known from the literature “7-17”, “7-29”, (WO2013 / 124228)Significantly improved post-emergence tolerance with respect to the crops Brassica napus (BRSNW), Glycine max (GLXMA), Oryza sativa (ORYSA), Triticum aestivum (TRZAS), and Zea mays (ZEAMX) at an application rate of 20 g or less per hectare. Tables C17-C28 below show the pre-emergence effects on various weeds of compounds according to the invention and a structurally similar compound known from the literature from WO2013 / 124228 at an application rate corresponding to 80 g / ha or less, obtained according to the aforementioned test protocol. Table C17 Compound ALOMY Application rate (effect in %) [g / ha] 1-2 (according to the invention) 80 80 7-6 (WO2013 / 124228) 50 80 Table C18 Compound ABUTH Application rate (effect in %) [g / ha] 1-2 (according to the invention) 100 20 7-6 (WO2013 / 124228) 40 20 1-7 (according to the invention) 100 20 7-17 (WO2013 / 124228) 30 20 1-11 (according to the invention) 100 20 7-12 (WO2013 / 124228) 0 20Table C19 Compound AMARE Application rate (efficacy in %) [g / ha] 1-1 (according to the invention) 100 20 7-18 (WO2013 / 124228) 70 20 1-2 (according to the invention) 100 20 7-6 (WO2013 / 124228) 70 20 1-11 (according to the invention) 90 20 7-12 (WO2013 / 124228) 10 20 BCS231028 Abroad - 73 - Table C20 Compound AVEFA Application rate (efficacy in %) [g / ha] 1-1 (according to the invention) 90 80 7-18 (WO2013 / 124228) 60 80 1-2 (according to the invention) 90 80 7-6 (WO2013 / 124228) 40 80 1-7 (according to the invention) 90 80 7-17 (WO2013 / 124228) 60 80 Table C21 Compound DIGSA Application rate (efficacy in %) [g / ha] 1-11 (according to the invention) 100 20 7-12 (WO2013 / 124228) 20 20 Table C22 Compound ECHCG Application rate (efficacy in %) [g / ha] 1-2 (according to the invention) 100 20 7-6 (WO2013 / 124228) 20 20 1-7 (according to the invention) 100 20 7-17 (WO2013 / 124228) 80 20 1-11 (according to the invention) 100 80 7-12 (WO2013 / 124228) 0 80Table C23 Compound MATIN Application rate (efficacy in %) [g / ha] 1-2 (according to the invention) 100 20 7-6 (WO2013 / 124228) 70 20 1-11 (according to the invention) 100 80 7-12 (WO2013 / 124228) 0 80 BCS231028 Foreign Countries - 74 - Table C24 Compound PHPBU Application rate (Effect in %) [g / ha] 1-11 (according to the invention) 80 20 7-12 (WO2013 / 124228) 0 20 1-2 (according to the invention) 100 80 7-6 (WO2013 / 124228) 70 80 Table C25 Compound POLCO Application rate (efficacy in %) [g / ha] 1-1 (according to the invention) 90 80 7-18 (WO2013 / 124228) 70 80 1-7 (according to the invention) 80 80 7-17 (WO2013 / 124228) 10 80 1-11 (according to the invention) 100 80 7-12 (WO2013 / 124228) 30 80 Table C26 Compound SETVI Application rate (effect in %) [g / ha] 1-1 (according to the invention) 100 20 7-18 (WO2013 / 124228) 60 20 1-2 (according to the invention) 100 20 7-6 (WO2013 / 124228) 80 20 1-11 (according to the invention) 90 80 7-12 (WO2013 / 124228) 20 80Table C27 Compound VERPE Application rate (efficacy in %) [g / ha] 1-1 (according to the invention) 100 80 7-18 (WO2013 / 124228) 80 80 1-2 (according to the invention) 100 80 7-6 (WO2013 / 124228) 20 80 BCS231028 Foreign Countries - 75 - Table C28 Compound VIOTR Application rate (Effect in %) [g / ha] 1-2 (according to the invention) 100 80 7-6 (WO2013 / 124228) 80 80 1-11 (according to the invention) 100 80 7-12 (WO2013 / 124228) 20 80As the results presented in Tables C17 to C28 show, compounds according to the invention (1-1, 1-2, 1-7, 1-11) have a significantly improved pre-emergence herbicidal activity against weeds such as Abutilon theophrasti (ABUTH), Alopecurus myosuroides (ALOMY), Amaranthus retroflexus (AMARE), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinochloa crus-galli (ECHCG), Matricaria inodora (MATIN), Pharbitis purpurea (PHBPU), Polygonum convolvulus (POLCO), Setaria viridis (SETVI), Veronica persica (VERPE) and Viola tricolor compared to the structurally similar compounds known from the literature “7-18”, “7-6”, “7-17”, “7-12”, (WO2013 / 124228). (VIOTR) at an application rate of 80 g of active substance or less per hectare.Tables C29-C32 below show the pre-emergence crop tolerances of compounds according to the invention and a structurally similar compound known from the literature from WO2013 / 124228 at an application rate corresponding to 80 g / ha and lower, obtained according to the aforementioned test procedure. Table C29 Compound BRSNW Application rate (Effect in %) [g / ha] 1-13 (according to the invention) 0. 80 7-29 (WO2013 / 124228) 60 80 Table C30 Compound GLXMA Application rate (efficacy in %) [g / ha] 1-13 (according to the invention) 0 80 7-29 (WO2013 / 124228) 20 80 BCS231028 Foreign countries - 76 - Table C31 Compound ORYSA Application rate (efficacy in %) [g / ha] 1-13 (according to the invention) 0 20 7-29 (WO2013 / 124228) 20 20 Table C32 Compound ZEAMX Application rate (efficacy in %) [g / ha] 1-7 (according to the invention) 0 80 7-17 (WO2013 / 124228) 20 80As the results presented in Tables C29 to C32 show, compounds according to the invention (1-7, 1-13) exhibit significantly improved pre-emergence tolerance with respect to the crop plants Brassica napus (BRSNW), Glycine max (GLXMA), Oryza sativa (ORYSA) and Zea mays (ZEAMX) at an application rate of 80 g and less per hectare compared to the structurally similar compounds “7-17”, “7-29”, (WO2013 / 124228).

Claims

BCS231028 Ausland - 77 - Patentansprüche 1. Sulfonimidoylbenzamide der Formel (I) oder deren Salze worin die Symbole folgende X bedeutet Halogen, Cyano, (C1-C6)-Alkyl, (C1-C6)-Alkoxy, (C1-C6)-Alkylthio, Halogen- (C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C3-C6)- Cycloalkyl, Z bedeutet Halogen, Cyano, (C1-C6)-Alkyl, Halogen-(C1-C6)-alkyl, (C2-C6)-Alkenyl, Halogen-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-Alkinyl, Halogen-(C 3 -C 6 )-alkinyl, (C 3 -C 6 )-Cycloalkyl, Halogen-(C 3 -C 6 )-cycloalkyl, Halogen-(C 1 -C 6 )-alkoxy, (C 1 -C 6 )-Alkylsulfonyl, W bedeutet Wasserstoff, Halogen, R bedeutet (C 1 -C 6 )-Alkyl, (C 3 -C 6 )-Cycloalkyl, (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6)-alkyl, (C 1 -C 6 )- Alkoxy-(C 1 -C 6 )-alkyl, R' is hydrogen, cyano, (C 1 -C 6 )-alkyl, R'' is hydrogen, (C1-C6)-alkylcarbonyl.

2. Sulfonimidoylbenzamides according to claim 1, wherein X is halogen, (C1-C3)-alkyl, (C1-C3)-alkoxy, (C3-C6)-cycloalkyl, Z is halogen, (C1-C3)-alkyl, halo-(C1-C3)-alkyl, (C3-C6)-cycloalkyl, halo-(C1-C3)-alkoxy, W is hydrogen, fluorine, R is (C1-C3)-alkyl, R' is hydrogen, R'' is hydrogen.

3. Sulfonimidoylbenzamides according to claim 1 or 2, wherein BCS231028 Foreign Countries - 78 - X is chlorine, methyl, ethyl, methoxy, cyclopropyl, Z is chlorine, methyl, difluoromethyl, trifluoromethyl, cyclopropyl, trifluoromethoxy, W is hydrogen, R is methyl, ethyl, R' is hydrogen, R'' is hydrogen.

4. Herbicidal compositions comprising at least one sulfonimidoylbenzamide according to any one of claims 1 to 3 in a mixture with formulation auxiliaries.

5. Herbicidal compositions according to claim 4 comprising at least one further pesticidally active substance from the group consisting of insecticides, acaricides, herbicides, fungicides, safeners, and growth regulators.

6. Method for controlling unwanted plants, characterized in that an effective amount of at least one sulfonimidoylbenzamide according to any one of claims 1 to 3 or of herbicidal compositions according to claim 4 or 5 is applied to the plants or to the site of unwanted plant growth. 7.Use of sulfonimidoylbenzamides of the formula (I) according to any one of claims 1 to 3 or of herbicidal compositions according to claim 4 or 5 for controlling unwanted plants.

8. Use according to claim 7, characterized in that the sulfonimidoylbenzamides of the formula (I) are employed for controlling unwanted plants in crops of useful plants.

9. Use according to claim 8, characterized in that the useful plants are transgenic useful plants.

Images